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Abstract

Current drug therapies have lost their effectiveness in controlling the fungal species
known as C. albicans; therefore, the need for newer drugs becomes crucial. Histatin 5
(Hst 5), a naturally occurring peptide found in the oral cavity, has demonstrated strong
effects on controlling candidiasis. Here, we have proposed that the adhesion of cells
through surface proteins is an important process. To allow the analysis of surface
proteins, the concept of on-whole cell tryptic digestions were developed. This on-target
approach allows for isolation of the peptides of interest, while greatly reducing digestion
times.
To study the effects of Histatin 5 on surface proteins, live cells were adhered to slides
pre-coated with human serum albumin (HSA); and subsequently, treatments with Hst 5
were done. Mass spectrometry was used to correlate changes in ion counts to protein
expressions. Preliminary work done by MALDI MS verified that changes in ion counts
occurred, as well as tentative protein identifications. Then, HPLC-ES-MS/MS was used
to verify proteins and their biological processes. A few proteins were seen from the cell
surface, where their presences indicated the success of our on-target approach. Three
other processes were found; virulence, mitochondrial associated and nucleic acid binding.
Hst 5 was shown to decrease the expression of proteins involved in the virulence,
supporting Hst 5 as an antifungal agent. The identified proteins involved in the last two
pathways have provided additional support for the speculation that cellular respiration in
the mitochondria may be the true target of Hst 5.
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Section 1 Introduction

1.1 Mass Spectrometry (MS) of Microorganisms

1.1.1 Protein Profiling for Taxonomy
The ability to differentiate microbial species can be beneficial, as it allows for rapid
clinical

identification

of

pathogenic

and

non-pathogenic

species.

Traditional

identification methods are based on morphology and biochemistry. Unfortunately, this
led to sample preparations spanning several days, which can hinder clinical applications.
As such, identification using the genome sequence is now the standard. Indeed the
genome does provide the most accurate identification; however, analysis of the genome is
time-consuming and challenging. The analysis of proteins has been recognized as a postgenomic science, allowing one to indirectly study the genome. Therefore, protein analysis
performed by mass spectrometry (MS) is an excellent alternative for microbial speciation.
Two “soft” ionization techniques, electrospray ionization (ESI) and matrix-assisted laser
desorption ionization (MALDI), allow for protein analyses. The detailed mechanisms of
both ionization techniques coupled with MS are discussed in Appendix 1.
In microbiology, MS offers significantly simplified sample preparations, a high degree of
certainty, and more importantly, rapid analyses of proteins. MS has been shown to
effectively determine taxonomy down to the genus, species and strain levels [1]. In this
approach, the process of profiling either the complete proteome or a sub-fraction of
proteins, are used for identification. This can be achieved by developing key mass-tocharge (m/z) signals, known as biomarkers, which are characteristic to specific
microorganisms. These biomarkers are like the microorganism’s fingerprint, and so by
incorporating them into a database, rapid identification is possible [2].
In 1998, Liu et al. successfully used this biomarker method for the identification
Escherichia coli from crude lysates [3]. In their work, cells were lysed open and the
1

resulting lysate was analyzed via MS. Due to the complexity of using cell lysates,
separation techniques like liquid chromatography (LC) are often used, therefore making
ESI MS more favourable. In Liu’s work, however, they developed their own cellulosebased molecular weight cut off microdialyzer for fractionation. Their work demonstrated
the need for a sample cleanup prior to mass spectral analyses. Despite this success, more
rapid methods are sought after as LC-ESI-MS has a lower sample throughput and is still
time-consuming.
MALDI MS offers several advantages with regards to biomarker fingerprinting. The
main improvement is the rate of data acquisition. In MALDI MS, larger amounts of data
can be analyzed over a set period of time. This is because many samples can be spotted
onto a single plate. Protein profiling for microorganisms using MALDI MS was first
introduced by Cain et al. in 1994 [4]. In their work, cells from the Pseudomonas species
were lysed using sonication, and the released proteins were analyzed. By comparing
spectra obtained from pure bacterial cells to those obtained from mixtures, they
developed biomarkers characteristic to each species. As a result, these biomarkers were
able to accurately identify the Pseudomonas species within mixtures.
Despite these successes, there was still one drawback in MS of microorganism speciation.
This would be the use of crude lysates. Lysates are biologically complex and almost
always require a sample cleanup to help improve detection. Because of this, methods
using whole intact cells, rather than lysates, became of interest. Anhalt and Fenselau were
able to use whole microbial cells for biomarker identification [5]. In their work, cells
from several bacterial species were directly inserted into the ion source of a pyrolysis
mass spectrometer. The gentle heating of the cells lead to partial vaporization, and the
resulting spectra were able to differentiate the species. Their success demonstrated that
using whole cells directly, instead of cellular fractions, was possible with the same
results.
With whole cells, both the use of ESI and MALDI, have been explored. Vaidyanathan et
al. reported using ESI MS by injecting suspensions of whole cells directly into the mass
spectrometer [6]. In addition, they were able to identify strains of bacteria without the use
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of LC. Unfortunately, for ESI MS clogging by the intact cells may occur. And yet again,
sample throughput is still limited due to rinsing and sample loading steps. Because of
this, MALDI MS seemed more as a suitable candidate for whole cell analyses.
With MALDI MS, intact cell sample handing and analyses become simpler. In general
the procedure for these analyses can be completed in three steps [7]. To start, fresh cells
of a colony are transferred from the media plate to the MALDI target. Samples are then
overlaid with a matrix, where α-cyano-4-hydroxycinnamic acid (CHCA) and sinapinic
acid (SA) were proven to produce better signals [8, 9]. And lastly, once dried, they can be
introduced into the mass spectrometer. Holland et al. successfully carried out this
described procedure towards identifying five bacterial strains in a mixture [8]. With cells
only needing to be transferred directly to the MALDI target, the application of MALDI
for microorganisms is limitless. It does not encounter needle clogging and MALDI MS is
more tolerant to higher salt concentrations. Together, MALDI MS seems to be more
appropriate in whole cell analysis.

1.1.2 Surface Proteins and Enzymatic Cleavages
Out of all proteins encoded by the genome, interest has shifted towards investigating the
surface proteome. The surface proteome encompasses all proteins present at the cell
surface under a specific condition and time [10]. These proteins localize to the
cytoplasmic membrane, membrane-cell wall interface or the cell wall [11]. There they
may be partially or completely exposed to the external environment. This meant that they
can be freely soluble, held within vesicles or surface-attached [12]. Surface proteins have
multiple functions that are vital to cell survival which include; transportation of nutrients,
acting as receptors for signalling pathways, acting as binding factors to other cells and
surfaces, and lastly, they have enzymatic activities [12].
Within microbiology, surface proteins are of particular importance as they play crucial
roles in establishing pathogenesis. The first step in causing an infection is to adhere to
host epithelial tissues [13]. Once attached, they can grow and ultimately invade the host
system [14]. Upon invasion, they can release toxins and cause serious health concerns.
3

Additionally, surface proteins allow for microorganisms to send appropriate signals to the
cytoplasm for defense against toxins and host immune responses [15]. For the host, the
first encounter is the surface proteome, and because of this, surface proteins may be
important for future drug therapies.
While the need for understanding surface proteins is crucial, not much is known about
them. This is majorly due to difficulties in defining their protein compositions and
surface topologies [14]. There are three methods that have been used for identifying
surface proteins. The first method involves the use of algorithms with genome analysis to
predict where surface proteins may be located [16]. This technique albeit rapid, was
neither fully reliable nor quantitative. A second approach would be to isolate membrane
and cell wall fractions from cytoplasmic ones [17]. Unfortunately, this suffered
contamination from cytoplasmic proteins. And lastly, antibodies that bind surface
proteins may be used [18]. In this method, surface proteins are predicted and tested
against antibodies to see whether binding occurs. When binding occurs, then there is
conformation of a surface protein. This has been shown to be successful, however, it was
very expensive and labour intensive. Overall, convenient methods are available for
identifying surface proteins, but, to minimize complications, others should be
investigated.
It was not until 2006 where the concept of limited proteolysis was coupled with MALDI
MS. In 2006, Rodriguez-Ortega et al. established a protocol for what was termed “cell
shaving", where proteins partially exposed on the outside of bacterial cells were isolated
[14]. In their protocol, live cells of group A Streptococcus were analyzed. Group A
referred to the sub-classification for specific carbohydrates present on the cell wall of the
β-hemolytic groups of microorganisms. β-hemolytic groups are those that completely
rupture red blood cells in their pathogenesis. Cells of group A Streptococcus were
subjected to the proteolytic enzymes, trypsin or proteinase K, to cleave peptides at the
surface. The use of enzymes to "shave" the cell surface allows for peptides to be released
into the surrounding buffer, allowing them for their separations from remaining cells. The
peptide-buffer mixture was collected and then analyzed with MADLI-MS. In theory,

4

these digestions should only target regions protruding outside of cells, hence, the peptides
can be said to belong to surface proteins.
Although studies involving surface digestions center on the use of MALDI MS for
analyses, it should be clarified that the use of ESI MS iwa possible. Phinney et al. used
limited proteolysis to understand how proteins of the Sindbis virus are arranged on the
cell surface [19]. It was determined that under different environmental conditions,
different protein regions are exposed and can be readily digested using trypsin. The
resulting peptides were released, separated by HPLC and then analyzed by ESI MS. In
addition, the recent development by Randall et al. demonstrated analyses of surface
digestions using ESI MS without a need for any separation [20]. They directly coupled
on-target surface protein sampling with nano-ESI inlet needle for mass spectral analyses.

1.2 Candida albicans (C. albicans)
Through collaboration with Dr. Walter Siqueira in Dentistry at UWO, our research has
become interested in studying microorganisms occupying the oral cavities and their
associated salivary proteins. Further knowledge can allow for a long term goal of
promoting oral health and defense against oral pathogens. From all of the
microorganisms in the oral cavity, our focus is towards the fungal species Candida
albicans (C. albicans), with its high increasing infection rates and ineffective oral
therapeutic treatments.
C. albicans can be found within the gastrointestinal and genitourinary tracts, as well as on
the surface of skins [21]. It exists within humans in a commensal relationship, where it
benefits without causing any damage. However, in individuals with compromised
immune systems, C. albicans can cause dangerous infections known as candidosis [22].
This includes individuals with acquired immune deficiency syndrome (AIDS), transplant
recipients, and those receiving chemotherapy [23]. There are two types of infections that
may occur, superficial and systemic. Superficial infections affect the skin, hair, nails and
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mucosal membranes [24]. Whereas systemic infections occur within major body organs
such as the kidney, heart and brain [25].
C. albicans exists in three distinct morphological forms; the unicellular yeast,
pseudohyphae with the starting growth of filaments, and as hyphae with fully grown
filaments. All three forms can be observed under varying growth; below 30°C or at pH
4.0, 30°C at pH 6.0., and 37°C at pH 7.0 or in N-acetylglucosamine, respectively. It is
because of this ability to adopt three forms, that C. albicans can be fatal. It enters the host
as the budding yeast, growing into the hyphal state to penetrate tissues [21]. And it is
only the hyphae that can initiate pathogenesis. As a result, the hyphal form carries the
most resilience to current therapeutic treatments [26]. In addition to these three states, C.
albicans can also form surface-attached communities called biofilms [21]. Biofilms are
cell communities encased in a matrix of extracellular polymeric substances. They can be
found on medical devices such as dentures, shunts, implants, peacemakers and catheters
[27]. Once growth starts on them, C. albicans becomes extremely difficult to remove,
where the only solution is to remove the device completely.
The most common way to treat candidiasis is to administer oral antifungal drugs. Four
categories of antifungal agents are available, classified according to their working
mechanism. The first class aims to disrupt the cell membrane, which the drug
amphotericin belongs [22]. The second group, including drugs like fluconazole, works to
inhibit the synthesis of ergosterol for the cell membrane [28]. Ergosterol is a key
component for maintaining cell membrane integrity. Third, is a group of drugs aimed
towards inhibiting the synthesis of the cell wall polysaccharide known as β-1,3-glucan
[22]. Lastly, is a group targeted towards the induction of incorrect ribonucleic acid
(RNA) synthesis and deoxyribonucleic acid (DNA) replication [22]. Despite these
different types, antifungal agents are losing their effectiveness in treatments. One
significant problem with using antifungal agents is that C. albicans has developed
resistance towards them [28]. In addition, the drug dose at the target site is not high
enough to illicit a response [22]. One simple solution to these complications may be to
develop additional drugs, however, this is challenging in itself. Fungal species are
eukaryotic which means they share common biological process as humans [29]. The
6

development of new drugs must be done in such a way that no serious side effects occur
in humans. Consequently, these drugs can cause serious side effects in humans. As such,
newer approaches targeted towards controlling C. albicans are needed.

1.3 Histatin 5 (Hst 5)
For infections to start, adhesion to oral surfaces must occur where C. albicans can begin
to colonize [30]. The process of adhesion is controlled by the development of an acquired
pellicle. This acquired pellicle develops on surfaces composed of about 130 proteins,
carbohydrates and lipids [31]. Of all the proteins, salivary proteins like histatins, statherin
and acidic proline-rich ones are of interest as they exhibit antifungal properties [32].
Vukosavljevic et al. have suggested that a newer approach to control C. albicans can be
done at the pellicle level by increasing the amount of these proteins [32]. One family of
proteins, the histatins, are of particular interest.
The histatin family differs from other proteins due to three factors; their unusually high
histidine content, lack of disulfide bonds, and their weak amphipathic nature [33]. They
are cationic peptides ranging in length from 7-38 amino acids [34]. These peptides are
naturally found within the human body, being secreted from only the partoid and
submandibular glands [35].
Histatin peptides come in three forms; Histatin 1 (Hst 1), Histatin 3 (Hst 3) and Histatin 5
(Hst 5), all containing 7 histidine residues, as shown above [35]. Hst 1 is composed of 50
amino acids with a molecular weight of 4929 Da. Hst 3 contains 51 amino acids with a
mass of 4063 Da. And Hst 5, has 25 amino acids with the smallest mass at 3037 Da. Hst
1 and 3 are derived from different structural genes, and Hst 5 is the proteolytic product of
Hst 3. The amino acid sequences of all three histatins are shown in Figure 1.1. The
effects of histatin peptides have been explored by Oppenheim et al., where they were
shown to inhibit the conversion of C. albicans to its pathogenic form. [36]. As a
consequence of this, Vukosavljevic et al. noticed the inability of cells to colonize denture
materials [30].
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Hst 1

MKFFVFALVL ALMISMISAD SHEKRHHGYR RKFHEKHHSH REFPFYGDYG

Hst 3

MKFFVFALIL ALMLSMTGAD SHAKRHHGYK RKFHEKHHSH RGYRSNYLYD N

Hst 5

DSHAKRHHGYKRKFHEKHHSHRGY

Figure 1.1. The histatin family is comprised of three histidine-rich peptides; Hst 1, Hst 3
and Hst 5. Hst 1 and Hst4 are derived from different structural genes, and Hst 5 is a
proteolytic product of Hst 3. Histatin peptides are naturally-occurring, with synthesis and
secretion from the parotid and submandibular glands.

From this family, Hst 5 has gained attention due to its higher potency. Oppenheim
discovered that using Hst 5, in comparison to the others, showed a 90-100% killing effect
at physiological conditions [37]. Two general theories have been proposed; the first
affects the cell membrane and the second, affects cellular respiration at the mitochondria.
The first theory stems from the general mechanism of how antibiotics work. In 1996, Raj
et al. discovered that antimicrobial agents work by adopting an amphipathic structure to
allow their insertion into the cell membrane [38] However, structural analysis of Hst 5
indicated it being weakly amphipathic [33]. Therefore, it cannot insert itself into the cell
membrane. Others have suggested that if Hst 5 is not being inserted, then perhaps the cell
membrane is being lysed instead [39]. Unfortunately, this concept was proven incorrect
by Baer et al. [40].
The theory regarding Hst 5 and its effects on the mitochondria was first defined by
Helmerhorst et al. [41]. They discovered that when Hst 5 was applied towards respiring
and non-respiring cells, the non-respiring ones were unaffected. In addition, they showed
that when Hst 5 is taken up by C. albicans, the peptides are localized towards the
mitochondria. This may be due to the similarities between mitochondria pre-sequences
and Hst 5. Recent work by Komatsu et al. further supplemented the effects of Hst 5 on
the mitochondria [42]. By investigating the expression before and after Hst 5 treatments,
changes in proteins involved in cellular respiration were observed. The inhibition of the
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Krebs cycle and loss of adenosine triphosphate (ATP) from cells lead to cell death.
Overall, this does provide further insight towards how Hst 5 works. However, the exact
mechanistic nature of Hst 5 on C. albicans remains unclear. The whole process is thought
to

possess

multiple

steps

with

many

missing

links

and

uncertainties.

1.4 Thesis Overview
MS for studying microorganisms has been gaining attention. The identification of
proteins expressed by these microbes is a newer approach into developing new
therapeutics against them. The fungal species, C. albicans, has become increasingly
effective in combating current oral antifungal agents. As a result, infection rates have
reached high numbers. One factor potentially contributing to its virulence is in its ability
to adhere to host surfaces. Once adhered, cells can easily colonize and penetrate tissues
for pathogenesis. With adhesion being the initial encounter between host and fungus, one
theory of how Hst 5 works can be hypothesized. Hst 5 may be altering the expression of
surface proteins, causing cells to no longer have the ability to adhere. Previous proteomic
work has been done by the Siqueira Lab. They have grown cells of C. albicans with Hst
5, and performed in-solution tryptic digestions resulting in the lysis of cells. Analyses of
the lysates were performed using HPLC-ESI-MS and database searches; however, the
quantity of resulting peptides was extensive. This made it challenging to identify key
proteins that may have any relevance.
Recent work accomplished by Moffa et al. in the Siqueira Lab has shown that upon
introducing Hst 5 within ninety minutes of cell adhesion, the number of cells remaining
has decreased [43]. Concurrently, they observed the inhibition of C. albicans into the
hyphal form in the presence of Hst 5. The precise cause of the decrease in adhesion has
yet to be explained; however, here we hypothesize the influence of Hst 5 on surface
proteins. By working concurrently with the Siqueira Lab, we can develop sample
preparations to mimic the adhesion process in the oral cavity. Then by performing
digestions on whole cells, we can reduce the sample pool and specifically isolate surface
proteins. Overall, this research will specifically address the following:
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a. The development of on-cell digestions for direct performance on C. albicans.
b. The adhesion of C. albicans to a solid support followed by treatment with the
Hst 5 peptide
c. Analyses by MS to detect changes in the expression of the identified proteins
following treatment.
Our results may help to identify key surface proteins and their roles in particular
biological pathways. Our combined results may supplement the understanding of Hst 5
and its influence on C. albicans. Furthermore, our developed surface digestion approach
may have potential applications towards understanding the pathogeneses of other
microorganisms.
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Section 2 Experimental
2.1 Reagents
Deionized water (18.2 Ω grade) was used for all experiments. Purification was done by
the Milli-Q Gradient A10 System (Millipore, USA).
A 0.1 mg/mL solution of human serum albumin (HSA) was used for cell adhesion
(Sigma Aldrich, USA). Frosted 76 x 26 mm glass microscope slides (VWR, Canada)
were used as the solid support for adhesion. Stock cultures of C. albicans in glycerol
were provided by the Siquiera Lab from Dentistry at University of Western Ontario. The
strain provided was ATCC90028. BD Difco Sabouraud dextrose agar (SDA) medium
(Becton Dickson and Company, USA) was used as the agar base for cultivating fungal
microorganisms. The growth of cells in solution was done using the media called yeast
nitrogen base (YNB) broth (Sigma Aldrich, USA) supplemented with sucrose (BioShop
Canada Inc, Canada). The media was sterilized and filtered using a BD 10 mL syringe
(Becton Dickson and Company, USA) through 25 mm IC Acrodisc syringe filters with a
0.45 µm Supor (PES) membrane (PALL Corporation, USA). 1X phosphate buffer
solution (PBS) was used in between for washings (Sigma Aldrich, USA). Histatin 5
(China Peptides Co., China) peptides were also provided by the Siquiera Lab.
Tosyl phenylalanyl chloromethyl ketone (TPCK)-treated trypsin from bovine pancreas
(Sigma Aldrich, USA) was used for all digestions. To activate digestions, trypsin was
resuspended in 50 mM ammonium bicarbonate at pH 8 (Sigma Aldrich, USA). Two
standard proteins, horse heart cytochrome c (Sigma Aldrich, USA) and horse heart
myoglobin (Sigma Aldrich, USA), were used for the development of on-target digestions.
During incubations and digestions, the Dako delimiting pen composed of 60-100% 1bromopropane and 5-10% dipentene (Cedarlane, Canada) was used to draw hydrophobic
circles.
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For MALDI MS analyses, peptides were mixed in a 1:1 (v/v) ratio with 5.5 mg/mL αcyano-4-hydroxycinnamic acid (CHCA) matrix solution containing 6 mM ammonium
phosphate monobasic, 50% acetonitrile and 0.1% trifluoroacetic acid (Sigma Aldrich,
USA).
Bovine serum albumin (BSA) was used as the standard for the bicinchoninic acid (BCA)
assays (Sigma Aldrich, USA). The Pierce BCA protein assay kit (Life Technologies,
USA) was used for peptide quantification. Both standards and the peptides were mixed
with the BCA reagent in a 96-well polystyrene microplate (Life Technologies, USA).
Before injection into the HPLC-ESI mass spectrometer, peptides underwent sample
cleanup via ZipTip (Millipore, USA). There were four solutions used during this
procedure. 50% acetonitrile (Sigma Aldrich, USA) was used to decontaminate the C18
column. 0.1% trifluoroacetic acid (Sigma Aldrich, USA) was then used to remove excess
acetonitrile. 0.5% trifluoroacetic acid was added to acidify peptides to allow binding to
the negatively-charged column. And lastly, a solution of 80% acetonitrile (Sigma
Aldrich, USA) was used to elude peptides off the column. After drying, peptides were
resuspended in 0.1% formic acid (Sigma Aldrich, USA). Solvent B (Sigma Aldrich,
USA), composed of 97.5% acetonitrile and 0.1% formic acid, was used in HPLC.

2.2 Instrumentation

2.2.1 MALDI MS

Samples were mixed in a 1:1 (v/v) ratio with 5.5 mg/mL CHCA matrix solutions prior to
analyses. All sample-matrix mixtures were spotted on a 384 well Opti-Tof 123x83 mm
SS MALDI plate (AB Sciex, MA, USA). The instrument is equipped with a 349 nm
OptiBeam On-Axis laser with a pulse rate at 400 Hz. Data acquisitions and processings
were done using TOF TOF Series Explorer and Data Explorer. The spectra were acquired
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in Reflectron positive mode, in the m/z range of 500-3500. Peak lists were created using
the following parameters; a peak density of 10 per 25 Da, minimal signal-to-noise (S/N)
of 10, minimum area of 50 and a maximum peak per spot of 200. Second fragmentation,
MS/MS, was also performed via post-source decay (PSD) using the 1 kV Positive
acquisition mode.

2.2.2 HPLC-ESI-MS/MS

The drying of peptides and analysis by HPLC-ESI-MS/MS were completed by the
Siqueira Lab. This setup allows for online liquid chromatography to be coupled with
direct introduction to the mass spectrometer for analyses.
Prior to mass spectral analyses, peptides underwent sample cleanup using C18 ZipTip
pipette tip columns. For the detailed protocol, please refer to Appendix 4. The eluted
peptides then drying to remove solvents and concentrate the peptides. This was
accomplished with the Vacufuge vacuum concentrator (Eppendorf, Germany). The
drying of peptides was done at ambient room temperature for 10 minutes at 14000 rpm.
Once dried, the peptides were resuspended in 0.1% formic acid.
HPLC was carried out on the Thermo Scientific Easy nLC II instrument (Thermo
Scientific, CA, USA). The 85 minute gradient composition ranged from 5 to 55% of
solvent B. The flow rate used was 200 nL/min at a pressure of 280 bar. The volume of
sample injected was 8 µL. Electrospray ionization was completed using a voltage of 2.0
kV with an ion transfer capillary temperature of 250.00°C.
Mass spectral analyses were performed on the Thermo Scientific linear trap quadrupole
(LTQ) Velos ion mass spectrometer (Thermo Scientific, USA). Positive-mode data
acquisitions and processing were done using Thermo Xcalibur 2.1.0 SP1.1162 software
(Thermo Scientific, USA). The MS scan range used was 0-2000 m/z. MS/MS was done
via collision induced dissociation (CID) using helium (He) as the inert gas.
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2.3 C. albicans Growth and Cell Culturing

Stock cultures of Candida albicans were provided by the Siqueira Lab from Dentistry at
The University of Western Ontario. The strain of cells used throughout all experiments
was ATCC90028. Prior to cell growth, SDA prepared plates were placed into a 37°C
oven overnight to ensure the absence of other microorganisms. The exact protocol for
preparing SDA plates is described in Appendix 2.
To start growth, cell colonies were grown on the plate containing the SDA medium.
Without thawing, a pipette tip of stock C. albicans was inoculated on the SDA plate. The
inoculated plate was incubated in a 37°C oven for 48 hours. Figure 2.1 is the resulting
colonies grown on the SDA plate.

Figure 2.1 C. albicans budding yeast colonies grown on SDA plates. Each dot
corresponds to a single colony.

One-third of a loop of the colonies on the SDA plate was transferred into about 45 mL of
YNB100. The protocol for preparing YNB100 is described in Appendix 2. The cells
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were then incubated at 37°C for 21 hours with shaking at 200 rpm. After this incubation,
optical density (OD) measurements were taken at 600 nm, giving what is known as OD600.

OD600 correlates the amount of cells present in the solution to the level of light

absorption. For C. albicans, the OD reading should be around 0.300. The measurements
were performed on the NanoDrop 2000C spectrophotometer (Thermo Fisher Scientific
Inc, USA). Following 21 hours, the solution was centrifuged (Avanti J-251 Centrifuge,
Beckman Coutler, USA) for 5 minutes at 6000 rpm. The pellet was then resuspended in
1X PBS, and the final C. albicans solution was stored at 4°C for no longer than one
week. For the cell lysate, the solution was centrifuged at 13 000 rpm for 5 minutes
instead. The supernatant was collected and analyzed by MALDI MS.

2.4 Adhesion of C. albicans to Glass Slides
The protocol for cell adhesion onto a solid support was adapted from Vukosavljevic et
al.[30]. In all adhesion experiments, glass slides were used as the platform in which cells
were adhered. The setup for the incubations is shown in Figure 2.2. Here inverted glass
vials containing wet cotton was used to cover the spots and retain humidity. vials
containing wet cotton was used to cover the spots and retain humidity. A maximum of
three spots per slide was used to prevent overcrowding of the vials. The Dako delimiting
pen was used to draw hydrophobic circles (shown in blue), therefore minimizing
spreading. The digestions were contained within hydrophobic circles of an inner diameter
of 0.60 mm. The volume of HSA, C. albicans and Hst 5 used was 25 µL. All incubations
were carried out on the bench top at ambient room temperature (RT).
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Figure 2.2. The setup for the preparation of slides. The attachment of cells, treatment
with Hst 5 and on-target digestions were carried out within the hydrophobic circle. The
spots were covered with an inverted vial, where soaked cotton was used to retain
moisture. A maximum of three spots per slide was used.

In order for the cells of C. albicans to adhere, a pre-existing layer of HSA was needed.
Before introducing solutions, the hydrophobic circles were drawn on the bare glass slide
first. To each circle, 25 µL of 0.1 mg/mL HSA was added and the spots were covered
with the vials. HSA incubation was done for 2 hours at RT. Once done, the spots were
washed three times with water. To verify that cells of C. albicans did attach, microscope
images of the slides were taken. Images were taken using the Leica DME basic
microscope with the imaging component DFC295 (Leica Microsystems, Canada).Upon
confirmation, Hst 5 was introduced next for the treatment.
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2.5 Treatment of Hst 5 on Adhered Cells

Two application methods of Hst 5 were investigated, pre-application and postapplication. The concentration of Hst 5 was 0.030 mg/mL, as suggested by the Siqueira
Lab. In the pre-application method, as shown in Figure 2.3C, Hst 5 was introduced prior
to adhesion of C. albicans. The HSA-coated slide was prepared as discussed above. Hst 5
was added for incubation next. This was carried out at RT for 2 hours. Afterwards, the
spots were washed thrice with 1X PBS. Last, 25 µL of the prepared C. albicans solution

Figure 2.3. Schematic for the preparation of C. albicans adhered slides. Red represents
HSA, green for C. albicans, and blue for Hst 5. (A), the control used was a HSA-C.
albicans slide. In (B), the post-application slide of HSA-C. albicans-Hst 5 is prepared.
And lastly in (C), is the pre-application slide of HSA-Hst 5-C. albicans.
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was introduced. The incubation was performed for 90 minutes at RT. Again, once
completed the spots were washed thrice with 1X PBS. This completed the attachment and
treatment, where on-target digestions were performed afterwards. This will be discussed
later.

For the post-application method, HSA was first added as already discussed. Following
this, 25 µL of the C. albicans solution was introduced next. The incubation was done for
90 minutes at RT. Washing of the spots were done three times with 1X PBS. And lastly,
25 µL of 0.030 mg/mL Hst 5 was applied for a 2 hour incubation at RT. The spots were
washed thrice before on-target digestions were performed. The preparation of the spots in
post-treatments are shown in Figure 2.3B.
Lower concentrations of Hst 5 used were also tested to determine the lowest threshold
that could be used. Two lower concentrations, 0.025 and 0.020 mg/mL, were considered
using both application methods. Glass slides were prepared according to Figure 2.3, and
the varying concentrations of Hst 5 were introduced in place of the 0.030 mg/mL dose.
Once prepared, the slides underwent on-target tryptic digests and peptides were collected
for MALDI MS analyses.

2.6 Tryptic Digestions

2.6.1 Standard Overnight Digestions for Test Proteins

Standard in-solution tryptic digestions were carried out prior to on-target digests. These
served as the basis for comparison of the developed on-target digestions. Two proteins,
cytochrome c and myoglobin, were chosen as the standard proteins. A ratio of 1:50
enzyme-to-protein (v/v) was used. The concentration of trypsin was 1.0 mg/mL in 50
mM ammonium bicarbonate with a pH of 8. Ammonium bicarbonate was incorporated
for the activation of trypsin. The concentration of proteins used for digestions was 1.0
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mg/mL in water. Once the standard proteins and trypsin were mixed together, the
resulting solution was placed in a 37°C oven for an overnight digestion. The peptides
were then lyophilized overnight and resuspended in water to a final concentration of 0.1
mg/mL. This peptide solution was mixed with CHCA for MALDI MS analyses.

2.6.2 Development of On-Target Tryptic Digestions
It should be noted that when the term “on-target” was used, it referred to performing the
digestions directly on the analyte. On-target digestions were developed as a substitution
to the standard overnight protocols. To start, they were first performed using the standard
proteins. These digestions were done on the MALDI plate on the bench top at room
temperature. They were initially designed using the standard proteins, cytochrome c and
myoglobin. 0.36 µL of 0.1 mg/mL standard protein was spotted onto the MALDI plate,
whereby, 0.36 µL of 1.0 mg/mL trypsin was layered on top for digestions. The digestions
occurred at ambient room temperature for ten minutes. Once completed, CHCA matrix
was laid over top and mass spectral analyses were performed. The digestion time was
also investigated to determine the optimal duration. To start, digestion times ranging
from; 15, 30 and 45 seconds; and 1, 2, 3, 4, 5, 10, 15, 20, 25, 30 and 60 minutes, were
explored on three replicates.
With success from the standard proteins, the on-target surface digestions were applied
towards the prepared C. albicans slides from Figure 2.3. Tryptic digestions with the
following conditions were used; a concentration for trypsin of 0.0015 mg/mL and a
digestion time of 10 minutes at RT. Again, during the digestions the spots were covered
with the glass vials. Once digestion was completed, the peptide-containing buffer was
recollected for mass spectral analyses.
The conditions described above represented the optimal experimental factors. Prior to
this, four experimental conditions were optimized. The first was to ensure the on-target
digest was not lysing the cell to produce unwanted background noise. To do so, a cell
lysate was prepared for comparison. Here, instead of centrifuging cells at a speed of 6000
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rpm, they were spun at 13000 rpm. This faster speed would cause cell lysis. The
supernatant was then collected for analyses. Next, five replicates of four final
concentrations of trypsin were tested; 0.0005, 0.0075, 0.001, 0.0015 and 0.002 mg/mL.
Lastly, the digestion time was re-evaluated for C. albicans. Here, digestion times of 5, 10,
15 and 20 minutes were investigated. Three replicates were performed for each.
In the case of MALDI MS, Fenselau reported that organic solvents can cause lysis which
would incorporate signals from internal cellular components [44]. Here, the cells were in
contact with three organic solvents from CHCA matrix. They were ammonium phosphate
monobasic, trifluoroacetic acid and acetonitrile. Figure 2.4 is a schematic of how the
digestions were carried out. The digested peptides as shown (step B) were separated
from the remaining cells. CHCA matrix was only incorporated afterwards (step C) As a
result, the influence of organic solvents on the cells was not an issue.

B
A

C

mass spectrometer

Figure 2.4 Schematic for on-target digestion followed by the introduction of CHCA
matrix. (A) trypsin was added to spots for digestion (B) Digested peptides were removed
from remaining cells (C) mixing of peptides with CHCA matrix for analyses

Depending on the mass spectral analyses, the next sample handlings varied. In the case of
MALDI MS, each spot was mixed in a 1:1 ratio with CHCA before spotting on the plate
for analyses. As for ESI MS/MS, it will be discussed in the following section.
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2.7 HPLC-ESI-MS/MS

Before analyses with HPLC-ESI-MS/MS, quantification for the cleaved peptides was
carried out. This was to ensure that the amount of our peptides were within the level of
detection of the mass spectrometer. The minimal amount of peptides needed was 2 µg.
For peptides, quantification can be accomplished using the BCA assay. The standard
protein used was bovine serum albumin (BSA). The exact protocol for the BCA assay is
presented in Appendix 3.
For the analyses with ESI MS/MS, the slides were prepared in the droplet method. Ontarget digestions using the optimal conditions of; 0.0015 mg/mL of trypsin and the
duration of ten minutes at ambient room temperature. Of the two application methods,
only slides prepared in the post-application were analyzed by MS.

2.8 Database Searches
All MALDI MS spectra were searched against the SwissProt protein database on
MASCOT

provided

by

Matrix

Science

(Peptide

Mass

Fingerprint,

http://www.matrixscience.com). The search parameters used for C. albicans were: (1)
trypsin with one missed cleavage, (2) fungi as the taxonomy, (3) a variable modification
for the oxidation of methionine and (4) a mass tolerance of ± 70 ppm.
All ESI MS/MS spectra were run through the Thermo Proteome Discoverer version
1.3.0.339 software (Thermo Fisher Scientific Inc., USA), using the algorithm known as
SEQUEST. The C. albicans database chosen to search results against was the UniProt
Knowledgebase, more commonly known as UniProtKB. (UniProt Consortium,
http://www.uniprot.org/, UK, Switzerland, USA). The data analysis program known as
SEQUEST was used for protein identification. The search parameters were as follows:
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(1) enzymatic cleavage by trypsin with 2 missed cleavages, (2) S/N of 1.5, (3) precursor
mass tolerance of ± 2 Da, (4) fragment mass tolerance of ± 0.8 Da, (5) modifications for
phosphorylation on serine and threonine, and oxidation on cytosine and methionine, and
(6) a minimum of 2 peptides per protein with high peptide confidences.
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Section 3 Results and Discussion

In Section 1, the use of MS in rapid whole cell analyses for microorganisms was
discussed. Of all microorganisms, infections caused by C. albicans have rapidly
progressed due to the development of resistant strains against current oral dugs. The
peptide Hst 5 has shown to have antifungal properties in controlling C. albicans in vivo,
but the precise mechanism of how Hst 5 is able to kill cells is not known. Current
research has proposed that Hst 5 affects cellular respiration at the mitochondria. This may
be so, but the influence of Hst 5 can be hypothesized to affect additional pathways. Here,
we hypothesize that Hst 5 may exert influence on surface proteins as well. Surface
proteins play crucial roles in allowing C. albicans to adhere to the oral cavity to initiate
pathogenesis. The treatment of C. albicans with Hst 5 may alter the expression of these
proteins. By performing surface digestions, we can quickly isolate surface exposed
peptides and protein identification via MS can allow further insight towards their role in
Hst 5.

3.1 Development of On-Target Digestions of Test Protein
Standards
In order to analyze surface proteins, a common approach is to study the peptides removed
from the surfaces of the intact cell. To accomplish this, site-specific enzymes are used to
cleave them off. Trypsin is commonly used for microorganism digestion, where it cleaves
on the C-terminal end of lysine and arginine residues. A typical workflow is to subject
cells to overnight proteolysis under conditions where cell integrity remains intact [45].
This allows for peptides to be released, which can be collected for mass spectral analyses.
Although this protocol was successful, it does have the drawback of being tedious and
time-consuming. Additionally, the longer incubation of cells with the enzyme may
potentially cause cell lysis. Because of these reasons, the use of on-target surface
digestions may be an improved substitution.
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With no established protocol for an on-target approach, digestions were initially
developed using standard proteins. First, myoglobin and then cytochrome c were
tryptically digested overnight at 37°C, serving as a standard to which the completeness of
the on-target digestions was compared. For the on-target digestions, the standards were
digested for ten minutes at ambient room temperature. A total of three replicates were
prepared for both proteins and the two digestion approaches. To begin, reference to
myoglobin will be discussed. The comparison of digested myoglobin from both digestion
methods are indicated in Figure 3.1. The asterisks indicated peptides belonging to
myoglobin.
Based solely on the number of asterisks, one can see that indeed the in-solution
digestions yielded a few more peptides than on-target. In addition, the relative peak
intensities were lower from on-target digestions. Although the appearances of the spectra
seemed identical, this was not the only indication of whether they were equivalent. To
supplement the spectra, MASCOT database searches were also completed. The results
were able to identify the protein, as well as determine the amount of sequence coverage.
The sequence coverage refers to the number of observed amino acid residues relative to
the total number in the protein. The database results for both digestions were successful
in identifying myoglobin as the protein. The average sequence coverage with standard
deviation (s.d.) of myoglobin was determined to be 77 s.d. 3% for in-solution, and 62 s.d.
5% for on-target. Likewise, the average coverage for cytochrome c was 83 s.d. 8% and
67 s.d. 3%, respectively. Despite the loss in the number of peptides and sequence
coverages, it can be concluded that the on-target method developed was sufficient.
Lastly, the on-target approach offers advantages such as; greatly reducing digestion times
from overnight to ten minutes, and minimizing the volumes of materials.
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Figure 3.1 MALDI MS spectra of the in-solution and on-target tryptic digests of
myoglobin. Three replicates were performed in total. The in-solution digestion was the
standard protocol used for digesting proteins. In the on-target approach, the digestion was
carried out for 10 minutes at room temperature. Asterisks (*) represent peptides of
myoglobin. The average sequence coverage with standard deviation for in-solution was
77 s.d. 3% and on-target was 62 s.d. 5%.

To help improve the completeness of the digestions, the investigation of digestion times
were explored. Both standard proteins were analyzed; however, here we will discuss
cytochrome c. The times ranging from seconds to one hour were tested. These included
times at 15, 30 and 45 seconds; and 1, 2, 3, 4, 5, 10, 15, 20, 25, 30 and 60 minutes. Three
replicates of cytochrome c digestions were prepared for each time mentioned. It was
determined that the shorter digestion times, from 15 seconds to 4 minutes, were not long
enough to allow trypsin to digest the standards. Likewise, increasing the digestions from
20 minutes until 1 hour provided no additional peaks relevant to cytochrome c. As such,
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it was determined that the critical times ranged from 5 to 15 minutes. To start the
comparisons, focus will be placed on three of the easily observed peptides with no missed
cleavages, m/z of 1168.62, 1598.56 and 1633.41, from cytochrome c. At five minutes, the
ion counts with standard deviations (s.d.) were; 30000 s.d. 75000, 2600 s.d. 150 and
17000 s.d. 2900 respectively. Between five and ten minutes, it was determined that at ten
minutes, the presence and intensity of peaks had increased. At ten minutes, the counts
were; 440000 s.d. 25000, 4800 s.d. 580, and 6500 s.d. 4700 respectively. This large of an
increase meant that trypsin was given enough time to effectively cleave off peptide
molecules. Therefore, this indicated that ten minutes allowed for a more completed
digestion. Five minutes was still not long enough for trypsin to reach and cleave the
peptides. At fifteen, a large drop in the ion counts was observed. The counts were;
380000 s.d. 26000, 430 s.d. 120, and 3800 s.d. 770 respectively. A possible explanation
for this would be the adsorption of peptides to the solid surface. The longer time would
allow for more adsorption, and consequently, less would be recovered for MS detection.
As a result, a loss in the ion counts would be expected. Due to this reason, it was
concluded that ten minutes was optimal for the digestion of cytochrome c. However, the
optimal digestion time is specific to each substrate, and thus it needs to be re-examined as
will be the case for proteins of C. albicans.
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Figure 3.2 MALDI MS spectra for the comparison of digestion time for the on-target
digestions of cytochrome c. Three replications of each time were analyzed. The digestion
times were varied from 5-15 minutes. Peaks belong to cytochrome c are marked with
asterisks. The three m/z peaks belong to peptides of cytochrome c discussed are labelled
with; 1168.62, 1598.56 and 1633.41.

3.2 C. albicans Adhesion on Glass Slides
The analyses of surface proteins for C. albicans were commonly done while in-solution.
In this workflow, cells were grown on SDA media, resuspended in a buffer and
enzymatically digested overnight. This may work as it will allow for the identification of
surface proteins; however, it does not truly represent the adhesion process. The adhesion
process becomes crucial as a requirement for C. albicans to penetrate the oral cavity. In
order for the expression of these specific proteins, the process of adhesion must have
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occurred or is occurring. Unfortunately, the factors driving the adhesion process remains
unknown. Factors such as the type of microorganism, material surface characteristics and
the presence of other proteins, can influence attachments.
To start, the ability of C. albicans to attach to a solid support was tested. For this, a bare
glass slide was immersed into a solution of cells, with the resulting image shown in
Figure 3.3A. As can be seen, no cells have attached to the slide, which indicated another
component was needed for adhesion. Chaffin demonstrated when beads were coated with
any of the extracellular matrix (ECM) proteins, the yeast and pseudohyphae forms bound
[46]. ECM proteins include albumin, fibronectin, fibrinogen, laminin and denatured
collagen. The way in which these proteins aid in adhesion remained unclear. They have
been hypothesized to help in three ways; first, to bind the substrata surfaces to allow for
colonization, second, to bind the surface of the microorganism and then colonize, and
lastly, to be present in the solution during the adhesion process [47].
Previous work completed by the Siqueira Lab has shown that C. albicans can bind to one
of the ECM proteins known as human serum albumin (HSA) [30]. HSA has been
identified as a relevant component in the oral cavity. It was reported to serve as a receptor
for initial adhesions [46]. By applying HSA to the glass slide first, thereby creating a precoated surface, C. albicans has the potential to attach. An image of a slide containing the
pre-existing layer of HSA was shown in Figure 3. It can be clearly seen that HSA was
necessary for cells to bind. The larger spots observed were cells that have begun to
adhere to one another, forming groups called colloids by a process known as flocculation
[2]. Despite washings of the slides, colloids remained, as highlighted by the red circle.
This was negligible, as the amount of cells was minimal.
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Figure 3.3 Microscope images of C. albicans adhered glass slides. (A) No C. albicans
adhesion on glass without HSA coating. (B) C. albicans adhered to HSA.

3.3. Influence of Hst 5 on Adhered Cells
With successful adhesion of C. albicans, Hst 5 was introduced into the system next. As
discussed in Section 2, Hst 5 was applied in two different methods; pre-application which
meant Hst 5 was applied before cell introduction and, post-application where Hst 5 was
introduced after cells. The 0.030 mg/mL concentration of Hst 5 will be used to discuss
the differences in both methods. By applying Hst 5 prior to C. albicans adhesion, cell
removal was observed. An image from the pre-application method is shown in Figure
3.4B. A control, where no Hst 5 was used, served as the basis to which the concentrations
were compared. The average values with standard deviations (s.d.) were listed in Table
3.1. The control had an average cell count of 110 s.d. 41, whereas pre-application was 13
s.d. 2. The reduction in cells may be attributed to the pre-existing layer of Hst 5. This
layer of Hst 5 seemed to act as a preventive layer, allowing fewer cells to attach. Equally
in its ability to cause cell removal was the post-application approach. Figure 3.4E was an
image of the resulting slide. The average cell counts for post-application was 16 s.d. 8,
which was roughly the same as pre-application. These results indicated that the influence
of Hst 5 on C. albicans was independent on when Hst 5 was introduced to the cells.
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Next, the effects of varying concentrations Hst 5 were also investigated. The
physiological concentration of Hst 5 found in the human body was reported to be 10-30
µM [48]. Thus far, only a concentration of 10 µM (0.030 mg/mL) has been applied
towards treating C. albicans. Lower Hst 5 concentrations became of interest in hopes of
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Figure 3.4 Microscope images of C. albicans adhered to slides. Four replicates were
imaged and cells were counted. Both pre-application and post-application methods were
investigated (A) Control, (B-D) Pre-application; 0.030, 0.025 and 0.020 mg/mL
respectively (E-G) Post-application; 0.030, 0.025 and 0.020 mg/mL respectively. The
corresponding average counts for each condition is shown in Table 3.1

30

Table 3.1 The average number with standard deviations (s.d.) of cells remaining when
exposed to Hst 5 from four replicates. Pre-application, Hst 5 before cells attachments, and
post-application, Hst 5 after cell attachments, were analyzed. The control had an average
of 110 s.d. 41 cells.
0.030 mg/mL Hst 5
0.025 mg/mL Hst 5 0.020 mg/mL Hst 5
Pre-Application

(A) 13 s.d. 2

(B) 18 s.d. 4

(C) 47 s.d. 7

Post-Application

(D) 16 s.d. 8

(E) 25 s.d. 5

(F) 42 s.d. 4

determining the lowest threshold that may be reached before no changes in adhesion were
observed. Two lower concentrations, 6.6 µM (0.020 mg/mL) and 8.2 µM (0.025 mg/mL)
were tested. Four repeats of each concentration was analyzed. Microscope images taken
for both concentrations in both application methods are shown in Figure 3.4C-D and F-G.
Again, our results showed that no difference between pre- and post-application of Hst 5.
For the determination of the lowest threshold of Hst 5, Table 3.1 indicated that 0.025
mg/mL was the lowest we could go. When compared to the control, it was determined
that all three of the Hst 5 concentrations demonstrated the ability to reduce the number of
adhered cells. Between 0.030 and 0.025 mg/mL, the two concentrations appeared to have
the same cell removing ability, as the average number of cells was similar. However,
upon using 0.020 mg/mL, the number of cells remaining increased greatly. The cell
counts

results

revealed

that

0.020

mg/mL

was

significantly

weaker.

3.4 On-Target Digestions of C. albicans

Ideally, on-target digestion will allow for the removal and sampling of peptides on the
surface of C. albicans without lysing the cells. The internal components from lysed cells
complicate mass spectral data, essentially by acting as non-informative background ions.
In the work done by Rodriguez-Ortega et al., cells of C. albicans were simply incubated
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with trypsin, thereby separating them from remaining cells [14]. Their work yielded only
proteins with origins at the cell surface. Because our developed digestion protocol varied
from theirs, the absence of cell lysis needed to be verified. By centrifuging cells at a
speed of 13000 rpm, the cell lysate was prepared. As a preliminary experiment, the mass
spectrum of the cell lysate was obtained. The results indicated that the spectrum for ontarget digestions produced substantially fewer peaks (spectrum not shown). Therefore, it
appeared that the on-target digestion was able to at least reduce the extent of cell lysis, if
not entirely preventing it.
The next task was to optimize the trypsin quantity for the on-target digestion of proteins
on adhered C. albicans. A total of five concentrations of trypsin were tested; 0.0005,
0.00075, 0.0010, 0.0015 and 0.0020 mg/mL. For each concentration explored, five
replicates were done. Of the five concentrations, the optimal concentration of trypsin was
determined to be 0.0015 mg/mL. Based on the intensity of a resulting peptide
characteristic to C. albicans, at m/z of 1758, insignificant intensities were obtained at the
two lowest concentrations studied. At 0.0010 mg/mL, the ion count and standard
deviation for this peak was 4000 s.d. 300. Then at 0.0015 mg/mL, it was 7000 s.d. 2000.
Finally, at 0.0020 mg/mL, the ion count decreased to 4000 s.d. 300. This indicated that
0.0015 mg/mL provided a more complete digestion than 0.0010 mg/mL.

3.4.1 Determining the Optimal On-Target Digestion Time for C. albicans
As already discussed in Section 3.1, the optimal digestion time determined from the test
standard proteins was ten minutes. Because the sample used here was different, the time
required for digestion was re-evaluated. Previous work done by Hernaez et al. performed
the isolation of surface peptides from C. albicans with variations in digestion times [49].
They investigated different times ranging from five to twenty minutes in five minute
intervals, whereby they concluded that five minutes was sufficient for the release of
easily accessible surface peptides. They also determined that as the time was increased,
the number of resulting peptides increased as well. Paralleling their work, times of five,
ten, fifteen and twenty minutes were tested and the resulting spectra were shown in
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Figure 3.5. Because the peaks pertaining to C. albicans were not known at that time,
specific comparisons of five replicates were made based on the peak with a m/z ratio
around 1500. This peak was neither an autolytic trypsin peak nor one from HSA;
therefore it was hypothesized to be one from C. albicans.
At five minutes, few peaks were observed in the mid to upper mass range. This was likely
due to the fact that trypsin was not given enough time to diffuse to the cells for the
removal of surface proteins. At ten minutes, a more completed digestion was observed.
This statement was made based on the appearance of the spectrum, and was supported by
the ion counts of the m/z peak around 1500. At five minutes, this peak was not present.
But at ten minutes, the count and standard deviation was 5100 s.d. 1300. Not only did the
count increase, but the appearance of more peaks signified a more completed digestion;
therefore, concluding five minutes was too short. Likewise, at fifteen minutes, the same
peaks seen at ten minutes were observed, however the intensities have decreased. This
was indicated by the reference peak which had an ion count of 3400 s.d. 1100. At twenty
minutes, it was expected the intensities of the peaks should have increased. However,
what happened was in fact the opposite. Here, not only did the peak at 1500 appear lower
in Figure 3.5, but the ion counts decreased to 3100 s.d. 1100, which was similar to fifteen
minutes. Together, the ion count and appearance of the spectra indicated that twenty
minutes was not better than fifteen. Interestingly, this produced parallel results to the
standard proteins in Section 3.1, where no additional information was gained as the
digestion times increased. Again, the same reasoning from before can be applied here.
The nonspecific adsorption of peptides to the slide decreases the number of ions available
for MS analyses.
Hernaez et al. have also reported that the longer the digestion, the greater the number of
peaks observed [49]. Our results here have shown otherwise. The numbers of peaks have
not increased by a significant amount when comparing ten, fifteen and twenty minutes.
Instead, only the ion counts have changed. It should be stressed that their digestions were
performed in-solution with 37ºC incubations. Digestions carried out while in-solution
offers a significant advantage as the number of cells is much larger. In contrast, our
digestions here become strongly influenced by the total number of cells attached to each
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slide, which easily differ between replicates. Based on these results, it was determined
that ten minutes provided the better digestion time.
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Figure 3.5 MALDI MS spectra for the comparison in surface digestion times of adhered
C. albicans treated with Hst 5. Five replicates were analyzed. Average ion counts and
standard deviations (s.d.) for the peak around 1500 were listed.
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3.5 Analysis of Peptides from C. albicans by MALDI MS
Following Treatments with Hst 5

With the capability of performing on-target surface digestions on C. albicans, we were
able to determine changes in the resulting peptides due to treatments with Hst 5, and
hopefully the results may provide insight towards which proteins and pathways are
involved in the mechanism of Hst 5. Both application methods of Hst 5 were analyzed
where four replicates were performed for each. From each replicate, the removal of
background signals such as keratin, matrix peaks, trypsin autolytic peaks, and peptides of
HSA was done. The data was searched against the C. albicans genome database, with
tentative protein identification. This led to a list of twenty m/z peaks assumed to be
characteristic only to C. albicans. All peaks have been assigned except for the m/z peak at
2294.92 in Table 3.2. This was because the C. albicans database remains incomplete.
The number of m/z peaks obtained was significantly lower than those when done insolution. In 2010, Hernaez et al. carried out a similar workflow to identify surface
proteins, and they were capable of identifying fifty proteins [49]. In their work, C.
albicans was treated with Hst 5, digested by trypsin and separated by HPLC. Mass
spectral analyses were performed using a MALDI TOF-TOF mass spectrometer. Because
their digestions were performed while in-solution, they were not limited the number of
cells. In our studies, the number of cells exposed to trypsin was limited. Only those that
have successfully adhered to HSA would have undergone digestion. As a result, it was
expected that fewer proteins would be identified. Nonetheless, with our rapid and more
targeted approach, a large number of peaks were observed.
The presence of antibiotics decreases microorganism adhesion depending on the
susceptibility of the species and the concentration of antibiotic used [47]. This can
regulate adhesion at both the cellular and molecular level. As a result, these changes were
elicited via which proteins were expressed. Hst 5, although not an antibiotic, may be
classified as an antimicrobial agent capable of causing changes in protein expressions. In
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MS, changes in protein expression can be linked semi-quantitatively via the ion counts of
the detected peptides. In this experiment, we are interested in

peaks that either

significantly decreased or increased after treatment with Hst 5.Hence, m/z peaks with no
changes were disregarded.
To begin, peaks with large decreases in their ion counts are discussed. Table 3.2 contains
the identified m/z peaks and their corresponding counts. The tentative protein
identification, amino acid sequences and their biological functions are listed as well. With
regards to the Hst application method, the results here demonstrated that both pre- and
post-treatments had a decreasing trend. It can be suggested that these proteins are the
cell’s defense mechanism against antifungal agents. For these proteins, it became difficult
to conclude that a decrease in ion count was truly representative of down regulation. This
was because the decrease may have also occurred as a result of the loss in cells. A loss in
cells would mean less peptides are available for analyses, therefore already constituting a
decrease in ion counts. Therefore, the use of ESI-MS/MS may provide validation of these
decreasing changes.
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Table 3.2. Database identified proteins from four replicates of on-target digestions of C. albicans treated with Hst 5. Both pre- and
post-application of Hst 5 have been included. Decreasing average ion counts and standard deviations (s.d.) have been listed. The
period (.) represents the site of enzyme cleavage and the dash (-) represents the end of the terminus.
Before
Treatment

PreApplication

PostApplication

(Avg. Counts
and s.d.)
150 s.d. 30
1400 s.d. 90
350 s.d. 70
770 s.d. 20

(Avg. Counts
and s.d.)
30 s.d. 10
0
220 s.d. 40
180 s.d. 180

(Avg. Counts
and s.d.)
0
700 s.d. 100
0
150 s.d. 60

m/z

802.00
1433.70
1677.80
1758.60

Amino Acid Sequence

IAQQDNGK.G
R.YGAGAGHPHRALAR.R
-.MSWFGFFDPDFDDFFGRPR.K
K.GQQVSRYGAGAGHPHR.A
K.YDDEKK.Q

Protein

Small heat shock protein 21

Cell wall protein RHD3

Functions

Virulence and stress response
Pathogenesis and cell wall
organization

R.ALFSGFR.F

Presequence translocatedassociated motor subunit
PAM17

1940 s.d. 260

K.TGHSGTLDPKVTGCLIVCIDR.A

Centromere/microtubule
binding protein CBF5

Chromosome migration

600 s.d. 80

630 s.d. 50

K.CVVVGDGAVGKTCLLISY
TTSK.F

Cell division control
Protein 42 homolog

hyphal formation, virulence,
morphogenesis

3600 s.d. 400

600 s.d. 80

630 s.d. 50

K.LALVGISFVPLVLLVTVLYGK.I

Alpha-factor-transporting
ATPase

ATPase activity and binding

7700 s.d. 3200

610 s.d. 910

580 s.d. 260

797.33

440 s.d. 120

0

230 s.d. 160

2184.74

6400 s.d. 30

1700 s.d. 2300

2214.50

3600 s.d. 400

2214.50
2294.92

2304.80

1600 s.d. 900

340 s.d. 4

280 s.d. 50

2310.00

1300 s.d. 200

0

420 s.d. 60

Transport of peptides from inner
membrane to mitochondrial
matrix

K.ENLDWFKPFDLARFPVDPK.D

Acetyl-coenzyme A
synthetase 1

ATP binding

R.VTDEILQLVPKPTVFKHALR.C

Poly(A) polymerase
PAPa

mRNA polyadenylation and
biofilm formation

K.ETDESYHELINKWENEMK.- +
Oxidation (M)
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Uncharacterized protein
YAE1

2322.82

1200 s.d. 120

200 s.d 30

640 s.d. 140

Adherence factor
K.FVSISVPILYGNHAIKLTPEK.R

2326.96

1200 s.d. 110

0

430 s.d. 40

R.VDVLLIIVHAITFSVSDKATGK.Y

R.AYMMDPWWSPSIEDQAIDR.I +
Oxidation (M)
K.LTSQEFWEHIFNIFEINK.F
K.DTFAAAALACGEKYYQVASSIR.
T
2334.50

1400 s.d. 600

300 s.d. 500

630 s.d. 50

Protein AF-9 homolog

Probable ferric reductase
transmembrane component
DNA repair protein
RAD5
Alpha-1,2mannosyltransferase

surface antigen mediating
adhesion and aggregation
DNA repair, transcription and
histone acetylation

Ion transport

DNA, ATP and Zn binding
protein mannosylation

K.ENLDWFKPFDLARFPVDPK.D

Acetyl-coenzyme A
synthetase 1

acetyl-coA biosynthesis

K.VQALILVPTRELALQTSQVVR.T

ATP and RNA binding (body
assembly)

2571.95

820 s.d. 90

0

310 s.d. 160

K.DEEDDESSDDDDSDDDDTALLL
K.E

ATP-dependent RNA
helicase DHH1
Pre-mRNA-splicing factor
WC15

3175.19

1300 s.d. 130

0

100 s.d. 10

MSEVNETCKPQACAIQNCLEKNG
YNESR.C + Oxidation (M)

Cx9C motif-containing
protein 4
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Pre-mRNA splicing
Involved in the transfer of
disulfide bonds to proteins
entering mitochondria

In the second part, we sought peaks with large increases in ion counts following Hst 5
treatment. Higher emphasis may be placed on these peaks because despite the loss of
cells due to Hst 5, an increase in ion counts was observed. From the peaks identified, the
only increases in counts were for proteins who made new appearances after treatment.
There was no increase for peaks already present prior to treatment. Table 3.3 contains the
four peaks and their changes in ion counts. In addition, their tentative protein
assignments, amino acid sequences and their biological functions were listed. Both
application methods were used and the ion counts from both are listed. The five peaks
verified the results seen in Table 3.2, in that both the pre- and post-application method
revealed the same increasing pattern. Based on this trend, it can be hypothesized that the
tentative proteins are undergoing an up-regulation in expression. It can be proposed that
these proteins aid Hst 5 in accessing C. albicans whereby it can elicit its antifungal
effects. Higher emphasis may be placed on these peaks because despite the loss of cells
due to Hst 5, a noticeable increase in counts was observed. Therefore, confirmation of
their identities will provide interesting insight on how Hst 5 works.
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Table 3.3. Database identified proteins from four replicates of on-target digestions of C. albicans treated with Hst 5. Both pre- and
post-application of Hst 5 have been included. Increasing average ion counts and standard deviations (s.d.) have been listed. The period
(.) represents the site of enzyme cleavage and the dash (-) represents the end of the terminus.

Before
Treatment

PreApplication

PostApplication

(Avg. Counts
and s.d.)

(Avg. Counts
and s.d.)

(Avg. Counts
and s.d.)

641.24
953.50

0
0

280 s.d. 80
560 s.d. 70

300 s.d. 10
420 s.d. 80

K.MESMK.Q + Oxidation (M)

669.24

0

710 s.d. 750

610 s.d. 190

K.YDDEK.K

695.35
841.44

0
0

1000 s.d. 100
170 s.d. 70

980 s.d. 110
43000 s.d 110

-.MAKTTK.V + Oxidation (M)

m/z

Amino Acid Sequence
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Protein

Increased
recombination centers
protein 6
Cell wall protein
RHD3
ATP-dependent RNA
helicase HAS1

Functions

Chromosomal rearrangement and
telomere healing
Pathogenesis and cell wall
organization
40S ribosomal subunit biogenesis

The proteins identified in both tables have cellular origins relating back to the cell
surface. These proteins were cell wall protein RHD3, small heat shock protein 21, cell
division

control

protein

homolog

42,

adherence

factor

and

alpha-1,2-

mannosyltransferase. This supported the assumption that the protocol developed for
digestion proteins on cell surfaces was successful. The experimental conditions chosen
were adequate to cleave surface proteins, yet mild enough to disfavour cell lysis. For
some of the identified proteins, origins pertaining to the nucleus were observed. Initially,
this contradicted the theory of digestion without cell lysis; that is, the only way nucleusassociated proteins can be identified was if the cells were lysed. It has been recently
discovered that certain proteins belong to a group known as moonlighting proteins.
Moonlighting proteins are multifunctional proteins that originate from one cellular
compartment, and then are transported to another whereby they perform different
functions. The protein, alpha-1,2-mannosyltransferase, has a potential of being a
moonlighting protein. Two locations, the Golgi apparatus and cell membrane, were
determined for this protein. However, its listed functions have roles associated at the cell
surface. Because of this, there may be a possibility for the presence of other moonlighting
proteins.
Another protein of particular interest was the small heat shock protein 21 (Hsp21). Not
only did it have an origin and functions at the cell surface, but its identification seemed
more reliable. In Table 3.2, four different masses and peptide sequences have been shown
to identify this protein. This not only meant that Hsp21 could be identified more
accurately, but there was a high possibility for its presence. Hsp21 was determined to
have functions as a coping mechanism for C. albicans in coping with thermal and
oxidative stresses [50]. Hst 5 may have functioned as a stressor, therefore, C. albicans
would have responded by changing the expression of Hsp21 in hopes of allowing cell
survival. With the mention of oxidative stresses, the expression of Hsp21 strongly
suggested the theory that Hst 5 affects cellular respiration may be correct.
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3.5.1 Limitations of MALDI MS Analyses
Thus far, we have demonstrated the ability of MALDI-MS to analyze large changes in
the protein expression after Hst 5 treatment. This was observed through large changes in
ion counts. The identities of these proteins and their roles in biological pathways, allows
focus on the key biological processes Hst 5 may influence. Unfortunately the proteins
identified in Tables 3.2 and Tables 3.3, were only tentative. To confirm their identities,
further identification would be required. Tandem MS (MS/MS) would allow for the
determination of their amino acid sequences. These sequences would be more specific,
allowing for a more specific identification.
MALDI MS/MS has been performed on the m/z peaks observed; however, the results
were inconclusive. One problem was the intensities of the observed peaks. To obtain a
sufficient MS/MS spectrum, the precursor peak must have an ion count of at least 2000.
When it is less, fragmentation becomes difficult and the spectrum can become noisy. This
was observed for the majority of the peaks. Their counts were not high enough to
undergo a second fragmentation. Figure A.1 was the spectrum obtained for the m/z peak
of 1677.86. Here, the second fragmentation was possible but as one can see, the spectrum
greatly suffered from background signals. The sequencing of the amino acids was
attempted, but due to the noise, it was difficult to distinguish between a signal from the
background and one from the amino acid. Automatic sequencing such as de novo
sequencing, can be used instead, however, this did not work for the acquired spectra.
To overcome this, additional sample cleanup was necessary. This will help remove any
signals from salts and buffers, allowing improved fragmentation. With that in mind, ESI
became a more suitable option as it can be easily coupled with LC. LC will allow for the
cleanup via further separation of the components. And with its ability to operate in a
continuous online mode, MS/MS can easily be acquired for all precursor ions as the
fractions leave the column. One focal point with ESI was its ability to automatically run
MS/MS spectra through databases such as SEQUEST, allowing for all probable amino
acid sequences within a selected species.
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Between the different Hst 5 application methods, both pre- and post-application offered
similar results. Both identified approximately the same number of m/z peaks, and the
changes in ion counts demonstrated the same trends. For further research however, with
interest towards clinical applications, it was decided that focus would be placed on postapplication. For example, take the situation where an individual has already contracted
the pathogen. This can represent the situation of C. albicans adhered to HSA in the oral
cavity. For them, administering Hst 5 would occur next, which is parallel to our postapplication method. In this aspect, we would be addressing the role of Hst 5 as a
treatment, rather than used as a prevention. In the next section, ESI MS/MS will be used
on post-application prepared slides. The appearance of the same list of m/z peaks from
MALDI MS will be searched in hopes of further confirming their identifications via
tandem MS.

3.6 Analysis of Peptides from C. albicans by HPLC-ESI-MS/MS
Following Treatment with Hst 5

3.6.1

Quantification of Total Peptide Concentration Prior to Sample
Injection

Prior to injecting the sample into the instrument, quantification of the peptides was
carried out. The linear trap quadrupole (LTQ) linear ion mass spectrometer used had a
lower level of detection at 0.002 mg. Since, peptides have molecular weights less than
4000 Da, a BCA assay was used. In the BCA assay, quantitation of proteins with low
molecular weight and peptides were done via reactions with Cu2+ ions. The specific
reactions involved in the BCA assay are discussed in Appendix 3. In addition, the
protocol for standard preparation and measurements are explained. Absorbance values of
the standard protein, bovine serum albumin (BSA), was used to extrapolate the quantity
of peptide. This assay was performed on the digested peptides from a single droplet spot
with a volume of 1.50 µL. The standard curve had an equation of y = 0.000x-0.021, R2 =
0.9662. It was therefore determined that from a digestion volume of 1.50 µL, the mass of
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peptides was 0.5050 mg/mL. Therefore, for a single spot with a volume of 1.50 µL, the
mass of the peptides was 0.7575 mg. To meet the lower level of detection, three spots
were combined as one replicate. From MALDI MS results, one significant limitation was
quantitative comparisons between data sets due to different cell counts. Therefore the
BCA assay, may somewhat act as a normalization in minimization large variations.

3.6.2 Database Search Results for Protein Identification

Prior to injection into the instrument, peptide solutions were dried and resuspended in
0.1% formic acid. Together, both HPLC and ESI MS/MS data were produced. However,
what was of more importance was the MS/MS data acquired. MS/MS spectra allowed for
the direct input into SEQUEST, an algorithm that searches against selected databases. All
spectra were run against the C. albicans database acquired from UniProt. In this way, all
mass spectral peaks were used, tentatively identifying all possible proteins correlating to
the observed masses. To be considered a protein of interest, it must have been identified
in both the untreated and treated samples with the same ascension number. In this way,
we can relate a change in protein expression as significant.
A total of six replicates were prepared and analyzed by HPLC-ESI-MS/MS. All resulting
spectra were searched against the C. albicans database, with the tentative protein
identifications shown in Table 3.4. Again, without completion of the database, m/z
assignments would not be possible. As an alternative, the concept of identifying peaks via
protein families was used. Those identified in this manner were represented with an
asterisk. Protein families include proteins who share similarities in sequences, structures
and functions. Unfortunately, even when assignments were done via protein families,
several proteins were still not identified. New protein entries are entered daily into these
databases, therefore when needed; the spectra can be searched again more frequently in
hopes of identification.
Upon comparison between MALDI and ESI MS results, the list of masses identified was
different. This can be due to different sample bias during both ionizations. Another
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probable explanation may be due to the sample cleanup during the ZipTip protocol.
When the ZipTip was used, the loss of peptides during numerous binding and washing
steps was expected. In the case of the digested peptides, the washings may have
potentially removed the peaks observed previously from MALDI MS results. This would
then produce a set of new masses following analyses. Another reason may be because
sample cleanup may have removed abundant contaminants. The presence of these
contaminants would mask the peptides of interest, which were already of lower
concentrations. As a result, this would allow for new peaks to be observed in ESI MS/MS
only. And lastly, there may be a possibility that the peaks identified in MALDI MS may
have been by chance. The performance of MS/MS would have allowed for us to
determine their amino acid sequences, and subsequently whether or not they were truly
peptides. However as already discussed, MS/MS was not possible with MALDI MS.
Similar to the MALDI MS results, Table 3.4 was examined for changes in ion counts. For
a change in ion count to be concluded, the standard deviations were taken into
consideration. When changes fell outside the standard deviation, a change was concluded.
Again, the two trends of decreasing and increasing counts were observed. Ion counts that
have decreased following Hst 5 exposure were bolded in blue, and those with increases
were bolded in red. Similar to the results from MALDI MS analyses, those with
increasing counts were of more interest. This was because even with the reduction of
cells adhered, an increase in expression for these proteins was seen. For those that did not
show changes outside the standard deviation, a change could not be concluded. As a
result, Table 3.4 categorizes the results according to which biological pathway they were
associated with.
Due to the difficulties in basing our results solely on ion changes, more emphasis will be
placed towards the biological pathways affected. Being able to identify specific
biological pathways may allow for better focus on how Hst 5 works. In addition, it will
allow research to become more targeted towards proteins in these key processes. Our
results in Table 3.4 have been classified into eight categories; (A) virulence, (B) surfaceassociated, (C) mitochondrial-associated, (D) DNA binding, (E) protein synthesis, (F)
signalling, (G) miscellaneous and (H) uncharacterized. For those in the miscellaneous
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group, no common pathway was found amongst the proteins. Those within the
uncharacterized group have no identification due to the incomplete C. albicans database.
However, frequent searches may be done as the new entries are added in hopes of
identification. The first four pathways will be our focus for the remaining of the
discussion.
Before discussing each specific pathway, the conflicting changes in each group will be
addressed. Conflicting changes are situations where one or more m/z peak exhibited an
opposite trend compared to the majority within same group. Table 3.4 contains number in
parenthesis beside each amino acid sequence. These values, known as XCorr, correspond
to the scoring system of the database searches. XCorr will score the number of fragment
ions common to two different peptides of the same precursor mass [51]. The crosscorrelation score is then presented from all peptide candidates provided from the
database. To be considered a "good" match, the XCorr value must be two or greater. In
the surface-associated proteins (Group B), only the mass of 1297.59 indicated an
opposing trend. As listed, the XCorr value was 1.82. This lower value suggested that the
identification of the protein, and consequently, its ion change, was not reliable. The same
can also be said for the proteins with masses 575.44 and 1297.59 of the DNA binding
proteins (Group D).
With previous work indicating the antifungal ability of Hst 5 in controlling C. albicans
[35] , proteins involved in virulence were assessed. The ion counts of these proteins were
expected to decrease following Hst 5 exposure, which was observed for all listed in (A).
The decrease for these proteins indicated that the ability of Hst 5 to affect the
pathogenesis of C. albicans. For example, the protein of the β-lactamase family (m/z of
4115.51) had a function with regards to resistance of C. albicans. This protein may
potentially aid C. albicans in withstanding the host's immune system. Therefore, a
decrease in its expression would lower the defense of C. albicans, making it susceptible
to the immune system in the host. Similarly, the protein kexin was identified to be
involved in the production of toxins. A decrease in expression could correlate to a
decrease in the amount of toxin produced, therefore weakening the pathogenesis of C.
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albicans. Overall, these results demonstrated the ability of Hst 5 to decrease the virulence
of C. albicans.
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Table 3.4. Database identified proteins from on-surface digestions by HPLC-ESI-MS/MS. Six replicates were analyzed from C.
albicans treated with Hst 5 in the post-application method. Average ion counts are listed with standard deviations (s.d.). Proteins
indicated with an asterisk (*) have between determined using their protein families. Blue represented those with decreasing ion counts,
and red for increasing ones. XCorr score values are listed in parenthesis.

Biological Pathways
A)

Mass

Ion Counts
Before
After

Virulence

1284.83

1295.87

3579.79
3895.36

27000
s.d.
9500

14000
s.d.
2800

66000
s.d.
1100
40000
s.d.
5000
36000
s.d.
4100

19000
s.d.
7000
31000
s.d.
36000
26000
s.d.
31000

15000
s.d.
1100

3200
s.d.
2700

51000
s.d.
12000

24000
s.d.
17000

4659.96

4115.51

Amino Acid Sequence

Protein Name

Functions

K.sLYTISPNKGK.R (2.52)

Transcriptional
regulator STP3

Filamentous growth

K.SKYNLPFAMK.E (3.75)

Candidapepsin-7

R.tKKWGLGWIK.N (1.61)

Integrase family*

HPQYsEACsAVmVVTYSSGSGEHIH
TTDIK (3.33)

Kexin

ELKTTVIVTSCFNNVCSETsITT
PKtAVtATtSK (3.1)
K.HLTLKSSTPASTLEYSTSIPPALATTSSS
LStESTtLttISR.S (3.25)

VTFVEKAtSTSTTNtTttTTTTTTTTTTTTTI
PVKR (3.23)
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Flocculin*

β-lactamase
family*

Supplies nutrients and
degrades proteins
involved in host's
immune system
DNA recognition
between phage and
bacterial attachment sites
Enzyme that produces
killer toxins

Needed for invasion and
pseudohyphae formation
in nitrogen starved
environment

Resistance

4121.03

31000
s.d.
23000

17000
s.d.
7200

1175.88

64000
s.d.
3900

22000
s.d.
1100

R.tINLDsQVK.Y (3.16)

1297.59

18000
s.d.
8800

51000
s.d.
5400

K.KPsTEDtFSK.Y (1.82)

Peroxisomal protein
family*

1295.87

66000
s.d.
1100

20000
s.d.
7000

mQTSISttTIEDHLHHYsPEESQKLLSRESSI
NTDLFK.E (3.13)

Bud site selection
protein BUD4

64000
s.d.
3900

22000
s.d.
1100

B) Surface-associated

C) Mitochondrialassociated

1175.88

1295.87

18000
s.d.
8800

19000
s.d.
7000
51000
s.d.
5400

1374.01

16000
s.d.
1300

10000
s.d.
3000

4659.96

15000
s.d.
1100

3200
s.d.
2700

PX domain*

3'(2'),5'bisphosphate
nucleotidase 2

Phosphatidylinositol
binding

Phosphatidylinositol
phosphorylation
Membrane component,
lipid metabolism and
decomposition of H2O2
Establishes the axial
budding pattern, induces
hyphal growth and has
role in epithelial
adherence

K.YMLLTLLtK.L (2.96)

K.LTtLISSIENK.I (2.96)
66000
s.d.
1100

1297.59

K.NVKVITTTTTtSPSSFSSSSSLMsPITPQT
PNIPKTPK.T (3.94)

R.NsIttEsVK.A (2.03)

R.TASGNIIPSSTGAAK.A (2.86)
K.StIVEEIYsNARSHLVQGNKEmGmALFN
ELLAINESIYGK.V (3.37)
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YAPbd/ALF4/Glomulin
family *

Aldehyde
hydrogenase
family*

Glyceraldehyde-3phosphate
dehydrogenase
Clustered
mitochondria
protein
Homolog

Stress response and
redox homeostasis,
induced by H2O2

Ooxidoreductase activity,
acting on the aldehyde or
oxo groups of donors,
NAD or NADP as
acceptor
NAD+ phosphorylation
and cell
biogenesis/degradation
Intracellular distribution
of mitochondria

D) DNA binding
575.44

804.77

1284.83

9700
s.d.
1000
42000
s.d.
22000
27000
s.d.
9500

28000
s.d.
6200
19000
s.d.
3100
14000
s.d.
2800

K.SLLSR.I (1.54)
K.QPAVFSR.I (2.56)

R.VASHsLsTsR.R (2.67)
K.NVIPAtItK.V (1.54)

18000
s.d.
8800

51000
s.d.
5400

47000
s.d.
36000
43000
s.d.
12000
63000
s.d.
1200
34000
s.d.
8900

30000
s.d.
23000
32000
s.d.
28000
14000
s.d.
1400
18000
s.d.
16000

3503.40

43000
s.d.
8300

31000
s.d.
25000

3939.14

36000
s.d.
24000

17000
s.d.
18000

1297.59

2806.76

3376.60

3331.28

3498.15

Telomerase reverse
transcriptase
family*

DNA binding

DNA polymerase

DNA-directed DNA
polymerase activity

Minichromosome
maintenance
protein 10
Spt6

DNA replication
Nucleic acid binding

K.EFTIGPFKcIK.W (1.56)

Transcriptional
regulatory
protein family *

Zn-ion binding & DNA
binding RNA
polymerase II
transcription factor
activity

R.TTPPTVsITGPNPsSSPAsASTNtSK.S
(3.60)

Phosphatase
family*

Chromosome segregation

K.SSPTSsATTTATtSVsISSLSLtMGKPKNS
K.L (3.15)

Mediator complex*

Cofactor to modulate
transcription

Minichromosome
maintenance
protein 10

DNA replication

K.LGSVLTtRSQLIEYELtTRtIFINCSA
ALK.I (3.11)

Spt6

Nucleic acid binding

R.EVIIKLSITRtHtPPPDSTtTTTPTTSIEK.T
(3.57)

Zn finger
domain *

Zn ion binding

K.GFTNTMISHIGFDPTGtsLNQNsTS
LGsK.S (3.21)

VSSYILDGNNSTKLPsPVLtHtTFDSRsDEG
QR (3.99)
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Basic leucine zipper
domain*

DNA binding
transcription factor
activity

4115.51

51000
s.d.
12000

24000
s.d.
17000

R.APQsIQLPPIQsFtKsQAVFPQSVRDSAPA
ANFNR.Y (3.12)

K.sStQMSSCtNsVTQTLDRLPKIVSTQQNN
LTPTSK.I (3.03)
4173.60

4368.59

4659.96

24000
s.d.
1200

33000
s.d.
21000

13000
s.d.
1200

7100
s.d.
1300

15000
s.d.
1100

3200
s.d.
2700

42000
s.d.
22000

19000
s.d.
3100

64000
s.d.
3900
27000
s.d.
9500

22000
s.d.
1100
14000
s.d.
2800

E) Protein synthesis
804.77

1175.88

1284.83

Transcription factor
and DNA binding
protein families*
Zn(2)-DNA binding
domain *

K.tVTsINGSPPPLEtAPsSHHNVPIDFIHFK
KESDR.T (3.12)

Uncharacterized
protein

K.NMQFPPYQVSsHNsSEtSQsIPNTPSITRQ
VESNTR.S (3.54)

Transcriptional
regulatory protein
LEU3

K.tPTTTTTTTTtANGNTSNGNTSNGNsTG
KTATAATATKSNtK (3.19)

Transcription
protein family*

MKImmIPTHHQtYNINTHQPPQQHQYLPP
PGtSYTSPR.A (3.12)

Transcription
factors and DNA
binding protein*

R.RSVSYSPGPsSIKSQLPHLTSSSTTtssVQ
SPPPPPPSQPPR.G (3.61)
K.QTSLNDK.C (2.54)

Zn (2) – DNA
binding domain*
Mannosyltransferase family*

R.VKIDSDK.S (1.51)

Protein transporter
SEC24

K.TKQFNDsKK.K (2.01)

Vesicle tethering
protein family*

K.tAGsNHNsEK.K (2.51)

Ribosomal RNAprocessing protein
12
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DNA binding RNA
polymerase II
transcription factor
activity and Zn ion
binding
DNA binding RNA
polymerase II
transcription factor
activity and Zn ion
binding
Sequence-specific DNA
binding RNA polymerase
II transcription factor
activity and Zn ion
binding
DNA binding RNA
polymerase II
transcription factor
activity and Zn ion
binding
Protein glycosylation

ER to Golgi vesiclemediated transport
Intracellular protein
transport

Protein binding

4121.03

4368.59

F) Signalling
3503.40

4115.51

4416.51

G)

31000
s.d.
23000

17000
s.d.
7200

33000
s.d.
21000

7100
± 1300

43000
s.d.
8300
31000
s.d.
20000
29000
s.d.
27000

31000
s.d.
25000
17000
s.d.
7200
16000
s.d.
1100

4659.96

15000
s.d.
1100

3200
s.d.
2700

575.44

9700
s.d.
1100

28000
s.d.
6200

1284.83

27000
s.d.
9500

14000
s.d.
2800

1901.71

7800
s.d.
3900

13000
s.d.
2300

Miscellaneous

K.FFsDNIANDLAtTTTTTTTTNTGAtSVHP
ILQVDAIK.Y (3.24)

CAS/CSE protein
family*

Intracellular protein
transport

K.ESSSTADQPSVVPPQESHKDTVETPKPE
VtEtsVEAtK.E (3.24)

Translation
initiation factor 4G

Protein biosynthesis

K.NPTPTPTPTPTPTPNNLAQGVDsSSTLD
VEtTLtGLtRR.I (3.21)

Imidazoleglycerol
phosphate synthase
cyclase subunit

Histidine biosynthesis

K.RSSITtPtPPLTTTHSSNGNGNGNVNVN
VNsK.R (3.30)

Peroxisome
transmembrane
receptor *
Pleckstrin
homology domain *

K.QSTTNTsTLssTtAASTLATSNNTQPDTY
TSTSTSIR.G (3.33)
R.QHPDPLSNQsNFNsNTINNYSNYRSsTR
SGLDPsQR.H (4.12)
K.DLPIGYILHmINLcPNIVsLNLGNLSLsT
DYEISRSTIHK.Y (3.68)

Rho GTPase
activating
protein domain*
F-box protein
COS111

K.WNKEKIELDsPLIVSYVSSLCNGGGGGI
ITNsTNSTttNSK (1.11)

Pentatricopeptide
repeat (PPR)
protein family*

R.SLNSR.I (3.15)

ATPase family*

R.NDsDtsLsK.E (1.66)

Insulin induced
protein family*

Protein import
Small GTPase mediated
signal transduction
Signal transduction
Signal transduction

Termination of G-protein
coupled receptor

ATP binding

Cholesterol synthesis

R.YtmNEVFK.V (2.02)
GYF domain*
K.NKATssSSStsRDTR.W (3.19)
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Leucine rich
repeats*

Protein-protein
interactions

3331.28
3331.28

63000
s.d.
1200

14000
s.d.
1400

63000
s.d.
1200

14000
s.d.
1400

ETsQFMGNAESEDLtGNGLLTSTL
AVLSSIS (3.15)

K.LSSLGNHGTtTTSSLSSSsSsSIsNNT
SIAK.I (3.46)

3376.60

CBS domain*
43000
s.d.
12000

3498.15

3895.36

4173.60

4421.03
3939.14

33000
s.d.
28000

R.KQQDQNEVAGAAAATTTTAtAtATAAT
NWKPK.N (3.21)
K.SSsLIKNsTsSNQSsPATSTNTSIVDVPIE
K.S (3.21)

34000
s.d.
8900

18000
s.d.
16000

36000
s.d.
4100
24000
s.d.
1200
32000
s.d.
19000
36000
s.d.
24000

26000
s.d.
31000
13000
s.d.
1200
17000
s.d.
7200
17000
s.d.
18000

9600
s,d.
4600
29000
s.d.
27000

5400
s.d.
1800

R.NNsTVSSTNSLmSNNsDTNtAATAATAA
TSGSTTNNVKR.M (3.38)

16000
s.d. 1100

R.NGtYSSsStSSSsTSSVSSSSATTANGESL
NSTTHNIQLER.T (2.89)

KAFSSsKLTSDSANStNStNsTSMSILGNDK
.D (3.16)
R.ISRPNGVGGISTSGSSSPTTEFVTPQAsK
sSVDQNKK.R (3.29)

Sensing of intracellular
metabolites

WD repeat protein*

Coordination of multiprotein complexes

CDK inhibitor
PHO81

Lipid metabolism

Ubiquitin
interacting
motif*

Ubiquitin metabolism

R.INNNNDKssILsNITTTNTTTGTGTTNTtT
VPSIKTK.R (4.24)

WD repeat protein*

Coordination of multiprotein complexes

R.HLILGYKItVVtDHQSLTsVMTSSSRPEN
NRMIR.W (3.83)

Aspartic peptidase
family*

Proteolysis

R.NVNGSGStNtNTMtRLDsTTIASSLFCRQ
LYFNLLSK.D (3.11)

4372.57

4416.15

Orf in C. albicans
Major Repeat
Sequence, RB2
Region
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Globin family*

Heme and oxygen
binding

Sec2p*

Vesicular transport

K.QNYVDPGQIAIKGLKGFVNLGAtCFMss
ILQtLIHNPLI.K.Y (3.69)
4659.96

15000
s.d.
1100

3200
s.d.
2700
K.YDKPmEDTEEIDDVtSISKsINEQID
DPFsQFNSVTLR.Y (3.51)

H) Uncharacterized
1175.88

1297.59

3331.28

3895.36

3939.14

64000
s.d.
4000
18000
s.d.
8800
63000
s.d.
1200
36000
s.d.
4100
36000
s.d.
24000

22000
s.d.
1100
51000
s.d.
5400
14000
s.d.
1400
26000
s.d.
31000
17000
s.d.
18000

K.tImtItIK.I (2.07)
R.NNTtVSKGRIK.V (1.51)
K.KHQtHILNVK.S (1.60)
R.IsNIITLNSSLSSSsSsSSSsSSLLLL
TLK.S (3.18)
K.TTPVMGNSStPSTVtANtNtGAYSTSSDT
AAKPTKK.A (3.14)
K.TTPVMGNSStPSTVtANtNtGAYSTSSDT
AAKPTKK.A (3.46)
K.TVCNWQtLGHTDEFEEstQFARGVSDtA
LVGGITK.L (2.18)

4115.51

4416.51

31000
s.d.
20000

29000
s.d.
27000

17000
s.d.
7200

16000
s.d.
1100

T.CGKSCFINSttANKLIsYNLFQSStEVDSI
GPTGSK.T (3.86)
K.TTPVMGNSsTPSTVTANTNTGAYSTSs
DtAAKPTKKATK.R (3.91)
R.ILLLLPLLGVtILTSKSSLESISLNsPSDSI
ALssSK.S (2.34)
K.STSSANIKtKPKPNTATtATTPTAtTATTt
ATTSSIDPTEK.D (2.59)
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Ubiquitin carboxylterminal hydrolase
Proteinserine/threonine
kinase

Anti-ubiquitination

ATP binding

4421.03

32000
s.d.
19000

17000
s.d.
7200

4368.59

33000
s.d.
21000

4372.57

9600
s.d.
4600

5400
s.d. 1800

15000
s.d.
1100

3200
s.d.
2700

4659.96

7100
s.d.
1300

R.LSGtNNPGsGsGsGGGGGGGANNNSLP
GYSVGSSIGRGRGLGR.G (1.89)
K.NYNQFKLIELDDSMNTTTTTTTTTTtTtt
TtTSTIGK.F (3.76)
K.SKsTTIHNQSNIHSEQISINDENNNKStst
STSTDTK.K (1.32)
K.SSGGSSDTKSVWIAtTGSDFASQSNSDS
sStASRNSSSSASR.Q (2.46)
K.EsEGVWGWsLQCLLLLFTKVNLRscDQ
LLICALVIR.E (2.99)
K.VILIGNSMTsRTTsSVRFFSIMLTVSLPIt
NILVsSELSK.V (3.11)
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Our original hypothesis was that surface proteins were affected following Hst 5
treatments. Hence, our results were examined for their presence and functions. Group (B)
in Table 3.4 listed the proteins found to have either cellular origins or functions
pertaining to the cell surface. The bud site selection protein BUD4 showed direct surface
association with functions directly associated with adhesion. With surface proteins, Hst 5
would affect the ability of C. albicans to adhere; therefore a decrease in ion counts was
expected. This did indeed occur as the ion counts went from 66000 ± 1100 before
treatment, to 20000 ± 7000 following treatment. This supported the microscope images
taken in Section 3.3.
At first glance, the number of proteins correlated to the cell surface may be discouraging,
but the chances of moonlighting proteins was probable. The protein glyceraldehyde-3phosphate dehydrogenase (GADPH) was discovered to be an anchorless surface protein
[52]. Anchorless surface proteins are similar to moonlighting proteins, in that they carry
functions at one cellular location and then are transported to the cell surface of unknown
function, but differ in that they originate at the cytoplasm. GADPH has been shown to be
involved in the Krebs cycle within the cytoplasm. But has also participated in the
colonization, persistence, and invasion of host tissues [53]. This dual functionality
demonstrates that perhaps the proteins identified may carry multiple roles, where the
effects at the cell surface still occur.
Current research has shown that Hst 5 influences C. albicans at the mitochondria through
energy metabolism, either through reactive oxygen species (ROS) formation, or via ATP
release [54, 55]. Similar to the work carried out here, Komatsu et al. used MS to measure
changes in protein expression at the mitochondrial level [56]. By comparing the level of
expression before and after Hst 5 treatment, they determined that Hst 5 caused the down
regulation of proteins participating in cellular respiration and adenosine triphosphate
(ATP) metabolism. Table 3.4 listed any mitochondrial-associated proteins in Group (C).
For all entries, it was also determined that the general trend of ion counts was decreasing
following Hst 5. This showed parallel results to Komatsu et al. Surprisingly, relatively
few proteins were listed. Only two the protein belonging to the aldehyde hydrogenase
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family and GADPH showed direct correlation to cellular respiration. The YAPbd/ALF4/Glomulin, did not show direct involvement to cellular respiration. However, the
protein family it belonged to proved otherwise. It is involved in a stress response induced
by hydrogen peroxide. Hydrogen peroxide has been shown to participate in the formation
of ROS at the mitochondrial level, thereby killing the cells [54]. The YAPbd/ALF4/Glomulin family protein may be involved as a defense mechanism against
hydrogen peroxide and ROS. This could imply that Hst 5 affects the expression of this
protein, therefore weakening the defense of C. albicans against ROS. Together, this
would indicate the possibility of Hst 5 affecting cellular respiration.
Unexpectedly, what was observed for the majority of the proteins was their connection to
the nucleic acid. These proteins were listed in Group (D) of Table 3.4. They have
functions relating to acid (DNA) or ribonucleic acid (RNA) binding, transcription and
regulation. Previous work has discovered that the structure of Hst 5 was determined to
have two main metal binding motifs, making it a metallopeptide [57]. The motif at the Nterminal, binds Cu2+ and Ni2+, and is known as the ATCUN-motif with the general
sequence of NH2-X-X-His. The second motif at the C-terminal, binds Zn2+, and has the
general sequence of His-Glu-X-X-His (HEXXH). It has been discovered that peptides
with these motifs behave as a DNA intercalator, delivering the peptide and metal cofactor
close enough to the DNA for binding [58]. Long et al. discovered that when the Ni/CuATCUN peptide complex formed, it had the ability to cleave nucleic acids in the
presence of co-reactants [59]. The ATCUN motif would bind the minor groove of DNA,
and the binding of Zn2+ ions at the HEXXH motif will increase the exposure of the side
chains of basic residues to increase DNA binding. Hst 5 has been shown to bind DNA,
however the exact roles of the two metal motifs remains unclear. The presence of both
motifs and its cationic nature favours the likelihood of its interaction with DNA for a
nuclease effect. With DNA damage and without DNA replication, the survival of C.
albicans is low. Many of the Group (D) proteins had DNA and Zn binding, which are key
participants in the ATCUN complex model. Therefore, based on these results, it may be
suggested that the nuclease ability of Hst 5 has occurred.
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At first, it seemed very plausible that Hst 5 as a metallopeptide, had another mechanism
whereby it only exerted influence at the nucleus. However, what was discovered was that
the affects at the nucleus were working in conjunction with effects on cellular respiration
at the mitochondria. Research done by Melino et al. showed specific function of the
ATCUN motif in oxidative and hydrolytic cleavage, through its nuclease activity [60].
The presence of the ATCUN motif bound to DNA led to a triple increase in ROS
production [61]. ROS can lead to organelle damage via DNA damage. Furthermore, it
was shown that the Cu-ATCUN complex was a necessary prerequisite for the oxidative
cleavages [62]. The mitochondria has been shown to house a large pool of Cu2+ ions [40].
This demonstrated that affects at the nucleus, were only side influences, where the true
processes affected were those pertaining to mitochondria and cellular respiration.
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Section 4 Concluding Remarks and Future Work

4.1 Conclusions

With the rapid increase in infections caused by C. albicans, new methods in minimizing
its effects are needed. The peptide known as Hst 5 has been shown to kills cells in vivo,
however, its mechanism remains unclear due to its complex multistep nature. Research
has become focused towards Hst 5 affecting cellular respiration at the mitochondria. In
this work, it was proposed that the adhesion of C. albicans to the oral cavity is crucial for
virulence. That Hst 5 may be affecting the surface proteins allowing for attachment. By
using MS and changes in ion counts, changes in protein expression may highlight which
proteins are affected.
The adhesion of live cells of C. albicans and treatment with Hst 5 was successful.
Following this, on-target tryptic digestions were developed to potentially isolate surface
proteins. In this way, digestions were shorter and can be quickly executed. Both MALDI
MS and ESI MS/MS showed the ability to detect changes in ion counts, and protein
expressions. MALDI MS and ESI MS/MS resulted in different m/z peaks, what was
prominent was that both techniques showed the same biological pathways were affected.
Both MS results contained proteins associated at the cell surface. This supported the
original assumption that the developed on-target digestions were able to cleave surface
proteins. This also suggested that surface proteins and adhesion may one of the many
ways in which Hst 5 controls C. albicans. Additionally, what was seen for the majority of
the remaining tentatively identified protein was their association with the nucleus. Dr.
Siqueira's previous work showed that the mitochondria was where Hst 5 exhibits its
therapeutic effects. The presence of these nucleus-associated proteins suggests that Hst 5
behaves like a metallopeptide. The binding of Hst 5 to DNA has been linked to produce
ROS. The presence of this species supports that cellular respiration was likely the
biological process that was affected.
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4.2 Future Work

In hopes of still exploring the influence of Hst 5 on surface proteins, the determination of
where the resulting peptides come from may be more sufficient. Indirectly, this can be
done through the use of immobilized trypsin. Trypsin can be immobilized on beads of
various materials such as glass or metal. With trypsin immobilized, the chances of
diffusion into the cell would be minimized. This would have the potential to then limit
protein cleavage within the cell and subsequently, their incorporation into our MS
analyses. Therefore, the observed peaks would only correlate to surface proteins.
A large complication seen with the ion counts, specifically, with the determination of
whether or not a change was observed. This was mainly because the degree of adhesion
could not be controlled and so, the number of cells present for each replicate remains
unknown. To address this, what can be done next is to incubate the slides with the same
number of cells. This way, variability in ion counts are more controlled and changes
would be more representative of the effects of Hst 5.
The tentative identification of proteins has been achieved, however, as the results
indicated, there were too many possibilities for a single observed m/z ratio. To address
this, additional replicates could be performed. The proteins identified from these
additional analyses may highlight which of the already observed proteins are more
significant.
Thus far, ESI MS/MS has been applied towards the post-application method of
introducing Hst 5. The results have identified proteins with changing expressions after
treatment. MALDI MS results have shown that the same proteins were identified
independent of when Hst 5 was introduced. The use of ESI MS/MS on pre-application
slides will be of interest next. The identification from this may result in the same proteins
as the post-application, provide more proteins, or they may identify a whole different set.
And lastly, the use of the developed on-target surface digestion can be applied towards
other microorganisms. By using this approach, it offers a fractionation technique for
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samples in which peptides may be analyzed. In this way, the sample pool becomes more
limited, therefore allowing focus on a specific set of proteins.
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Appendices

Appendix 1: Mass Spectrometry

Mass spectrometry (MS) is an analytical technique capable of correlating measured massto-charge (m/z) ratios of ions generated from samples to their intensities. From acquired
measurements, a mass spectrum is generated whereby the m/z ratios are plotted along the
x-axis, and the relative ion intensities on the y-axis. From the spectra, information such as
masses, isotopic patterns and even structures can be determined. In MS, the sample is
first introduced into the instrument, whereby it undergoes ionization under high vacuum
to produce either singly or multiply charged ions. These ions are then accelerated, and it
is in the mass analyzer, where the ions are separated based on their m/z ratios. As a result,
the separations allow for ions to reach the detector at different times leading to the mass
spectrum.
Small molecules (<500 Da) with a single functional group predominantly give rise to
singly charged molecules. They can either be [M+H]+ in positive mode, or [M-H]- in
negative mode. Larger molecules containing several functional sites give rise to multiply
charged ions with a general form of [M+nH]n+, such as [M+2H]2+. Additionally, adducts
can also occur with salts such as; [M+Na]+, [M+K]+, [M+formate]-, and [M+acetate]-.
Once ions are produced, they must be separated according to their m/z ratios. This is
accomplished by mass analyzers. The choice of which mass analyzer is suitable for which
mass spectrometer depends on factors such as mass range, resolution and sensitivity [63].
There are four commonly seen mass analyzers in research today; quadrupole and ion
traps, time-of-flight (TOF), orbitrap and cyclotron. Focus will be placed on quadrupole
and ion traps commonly seen with ESI systems, and TOF seen with MALDI systems.
The quadrupole mass analyzer consists of four oppositely charged, two are positive and
two are negative, parallel rods in which radiofrequency (RF) and direct current (DC) can
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be applied [63]. At one end is the ion source, with the detector at the other. When only
RF is applied, all masses are able to pass through. And when only DC is applied, all
masses are neutralized by coming into contact with the charged rods. When using a
combination of RF and DC, ions of certain masses are able to pass through and reach the
detector, therefore acting as a mass filter. Additionally, ions can become trapped within
the quadrupole to function as an ion trap. There are two types, linear and nonlinear,
where emphasis will be placed on linear ion traps. In a linear ion trap, both ends of the
quadrupole are set to carry the same charge as the ion that one wishes to trap. The
entrance will be set at a lower voltage than the exit. Damping gas will then be introduced,
causing ions to lose kinetic energy. As a consequence, ions cannot pass through and
become trapped. The quadrupole carries its own advantages; it has a low cost, allows for
easy automation and is physically small in size.
TOF analyzers, commonly seen with MALDI mass spectrometers, are well suited for
pulsed ion sources [64]. In TOF analyzers, ions are accelerated into a drift region of
known length. Lower masses travel down the tube in shorter times due to faster speeds.
In comparison, heavier masses take longer to travel due to slower speeds. These
analyzers can operate in two modes, linear and reflectron. In linear mode, ions simply
travel down the flight tube until they reach the detector. Ions with the same mass will
have different potential energies, reaching the detector at different times. Consequently,
this causes a dispersion effect leading to low resolution. To correct for this occurrence, a
reflector, which will causes ions to reverse directions, can be used in the reflectron mode.
In this mode, ions with higher kinetic energies penetrate the reflector more deeply,
reaching the detector later. Ions with lower kinetic energies do not penetrate as much and
so will reach the detector early. By operating in the reflectron mode, dispersion is
minimized leading to improved resolution.
The initial ions produced, known as the precursor ions, can undergo a second
fragmentation in what is known as tandem MS (MS/MS). In MS/MS, precursor ions from
the first ionization are chosen and undergo fragmentation. The second fragmentation can
be done in two ways, collision-induced dissociation (CID) and post source decay (PSD).
In CID, fragmentation is accomplished by colliding the excited precursor ions with an
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inert gas such as nitrogen, helium or argon [65]. As a result, the precursor ions become
unstable and will decompose into the fragment ions. MS/MS spectra will give m/z ratios
and intensities for all fragment ions of single precursor. By operating CID at lower
energies, fragmentation occurs at the amide bond between amino acids, instead of at the
side chain groups [66].

In PSD, fragmentation is accomplished by the laser. The

precursor ion is selected using an ion gate, where it then travels to a field free region for
fragmentation [67]. In both cases, the resulting spectra allows for the amino acid
sequences of peptides to be determined.
Many types of ionization techniques exist today; where they can are categorized as
“hard” or “soft”, depending on their ability to keep the analyte molecules intact during
ionization. “Hard” ionization fragments analytes into their daughter ions which can
provide structural information. One “hard” ionization technique commonly used is
electron ionization (EI). In this, an electron beam is based through the gas-phased sample,
whereby molecules collide with the neutral analyte to give fragmented ions. An
application of this would be to study the structures of organic and inorganic molecules.
However, with a developing interest in studying whole intact molecules, “hard”
ionization was incapable of doing so. As such, with the development of “soft” ionization
where little fragmentation occurs, molecules remain intact. This then allows for ions to be
generated from large, non-volatile compounds. Overall this makes the analyses of
biological compounds such as polysaccharides, drug metabolites and proteins possible.
Today, there are two “soft” ionization methods, electrospray ionization (ESI) and matrixassisted laser desorption ionization (MALDI), widely used in scientific fields. Both will
be discussed in greater details in section below.

A.1.1 Electrospray Ionization (ESI)
Since 1968, ESI has been incorporated largely into analyzing biomolecules. Figure A.1 is
a schematic describing the process of ionization. To start, a dilute polar solution
containing the analyte first flows through a hypodermic needle at a low flow rate [68].
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This needle will charge the surface of liquid passing through, where Coulombic forces
disperse it into charged droplets. As the droplets drift towards the end of the chamber,
evaporation of the surrounding solvent occurs, thereby decreasing its diameter. As a
consequence, the charge density on the surface will increase until it reaches its Rayleigh
limit. Once this limit occurs, a Coulombic explosion occurs were daughter droplets are
produced. This process of solvent evaporation and explosion repeats until the magnetic
field is strong enough to desorb ions. The resulting charged droplets are then suitable for
mass spectral analyses. The ions produced in ESI carry multiple charges with the general
formula of [M+nH]n in positive mode, and [M-nH]n in negative mode. This multiple
charging allows for analysis or proteins and peptides with limited m/z range analyzers.
For small molecules (< 2000 Da) such as peptides; singly, doubly or triply charged ions
are common seen. For large molecules (> 2000 Da) such as proteins, series of multiply
charged ions are observed.

Figure A.1. Schematic for electrospray ionization (ESI). The sample-containing solution
exits the charged needle as an aerosol. Upon desolvation, the aerosol diminishes in size
until a Coulombic explosion occurs, producing daughter ions which move towards the
inlet of the mass spectrometer.

With the development of ESI, studying large biomolecules became an area of interest.
However, along with these analytes, came their complex cellular mixtures. Because of
this complexity, spectra became too difficult to interpret. As a result, this led to a need for
chromatographic separations. With the coupling of liquid chromatography (LC) and ESI,
giving LC-ESI, a continuous stream of liquid sample can be directly introduced into the
mass spectrometer. Individually, LC is described below followed by a detailed
explanation of LC-ESI-MS as a hyphenated technique.
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To start, the sample mixture first undergoes analytical separation by LC. In LC, the
partitioning of analyte molecules is based on physical factors such as their solubility in
water and organic solvents, net charge and size [69]. In particular, separations are
accomplished by using the varying affinities of compounds towards two phases, either
the mobile or stationary phase. The mobile phase is a solution mixture containing the
analyte. This is injected into the column and continuously flows throughout. In contrast,
the stationary phase consists of porous beads, packed and held within the separating
column. As the components elute off the column, their signals are detected using UV,
fluorescence or electrical conductivity. The resulting measurements are presented as a
chromatogram, which plots the signal response of the components against their retention
times. With the combination of retention times, peak intensities and peak areas,
components can be successfully identified. In 1970, a variation of LC known as high
performance liquid chromatography (HPLC) was developed. In HPLC, high pressure is
used to generate the flow needed for the solution to pass through the column. Today,
HPLC is one of the most commonly used chromatographic techniques used. In LC, the
mobile phase moves along the column with very little pressure. However, HPLC differs
as it uses much high pressures to generate the flow rate of the mobile phase.
Within LC, there are two types known as normal phase liquid chromatography (NPLC)
and reverse phase liquid chromatography (RPLC). They are differentiated by the type of
mobile and stationary phases used. In NPLC, the stationary phase commonly used is
silica or organic materials with functionalities like cyano or amino groups. Because of
these, the stationary phase is a polar phase. The mobile phase will then be nonpolar,
where water and organic solvents are common. As the molecules partition between the
two phases, the order of elution will be least polar molecules first, and the more polar
ones later on. In order to elute the polar compounds, solvents of increasing polarity are
used. In RPLC, the stationary phase is composed of hydrocarbons such as C 18, making it
nonpolar . As for the mobile phase, it is typically a mixture of water and organic solvents.
Therefore, from this alone, one can see that this type of chromatography has been termed
“reverse” as it is the opposite of NPLC. The order of elution is thus, from highly polar
compounds to nonpolar ones. For nonpolar compounds, solvents of higher
hydrophobicity will be needed to elute compounds from the column.
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By using LC alone, separation of mixtures can be done via the competition of the mobile
or stationary phases for analytes. However, a significant problem that may arise is when
components elute at very similar retention times. This leads to overlap of peaks and
identification is not as accurate. By introducing MS as the detector, mass spectra will
supplement the chromatographic separations. In a LC-ESI-MS setup, as separations elute
off the column, they undergo the “soft” ionization next. This can be achieved in either the
online or offline modes. In online, the elution of compounds and ionization are
continuous. In offline, eluted fractions are collected first and then introduced into the
mass spectrometer. Of these two modes, online continuous ionization is preferred. In this
mode, a metal capillary is used instead of the hypodermic needle described previously.
The sample solution is pumped through the HPLC inlet and nebulized at the end to form
the spray. The resulting ionic species will then enter a capillary that carries them into the
high vacuum for mass spectral analyses. Overall, this will provide sufficient information
where masses and structures from MS, will complement the observed retention times of
LC.

A.1.2 Matrix-assisted Laser Desorption Ionization (MALDI)
The term “matrix-assisted” laser desorption was first introduced by Karas and colleagues
in 1985 [70]. In their work, a 1:1 ratio mixture of the amino acids alanine and tryptophan
underwent ionization and mass spectrometry at a wavelength at 266 nm. At this
wavelength, alanine was incapable of ionizing. However, when they analyzed the
mixture, a strong signal was observed for both alanine and tryptophan. Because of this
observation, they proposed that tryptophan acted as an absorbing matrix which aided ion
formation of alanine. It was not until 1989 where laser desorption ionization of large
intact molecules was possible. Tanaka et al. developed the concept of MALDI that is
used in research today [71]. In their research, the new sample preparation called
“ultrafine metal plus liquid matrix method” was developed. By combining the use of a
conductive metal and the “matrix-assisted” laser desorption discovered by Karas, they
were able to ionize an organic compound up to 34 kDa. Tanaka and his colleagues were
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able to demonstrate the capability of MALDI for ionizing large molecules, in particular,
biomolecules. In research today, the concepts of MALDI discovered by Karas and
Tanaka remain the same. Both a conductive metal plate and a matrix are used to aid in
ionization.
One large difference between MALDI in the past and present is the matrices being used.
As a matrix, the compound must absorb light in the UV region. As such, matrices must
absorb at the same wavelength as the laser being used. Consequently, in the past, only
molecules carrying aromatic residues were analyzed using MALDI [72]. Because not
many aromatic residues may be present, it was clear that the need for a compound to aid
ionization was necessary. Therefore, due to this lack of one, matrices were developed.
The theory behind developing matrices was to turn non-ultraviolet (UV) absorbing
molecules to ones that could. To qualify as a matrix, the compound must be relatively
water-soluble, not too volatile to prevent rapid evaporation, and it must not be too

Figure A.2. The schematic for matrix-assisted laser desorption ionization (MALDI).
Here, the analyte is mixed with a matrix in a 1:1 ratio and spotted onto the target. Upon
air-drying, crystallization occurs between matrix and analyte. A laser is used to desorb
these molecules, producing singly-charged ions that can be introduced into the mass
spectrometer.

chemically reactive [72]. Following these requirements, there are three matrices
commonly

used

today;

α-cyano-4-hydroxycinnamic

acid

(CHCA),

2.5-

dihyroxybenzenoic acid (DHB) and sinapinic acid (SA). They can be divided into two
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categories; derivatives of cinnamic acid which include CHCA and SA, and derivatives of
aromatic compounds where DHB lies. Matrices contain functional groups such as –OH, –
SH or –NH, which can supply the proton needed for protonation [73].
In MALDI, analytes are dissolved in a solution containing excess matrix, where typically
a 1:1 volume-to-volume ratio is used. The amount of matrix must be excessive enough to
completely solvate the analyte. This sample-matrix mixture is then spotted onto a MALDI
target, typically a conductive metal plate, where the spots are allowed to air-dry. Upon
drying, crystallization between the analyte and matrix occurs. Once dried, the target can
be introduced into the mass spectrometer. During ionization, as shown in Figure A.2, a
laser beam will hit the spots where absorption of light by the matrix occurs. Two
common lasers are seen today; the first is nitrogen laser with a wavelength of 337 nm,
and second the neodymeium-doped yttrium nitrogen aluminum garnet (Nd:YAG).
Nd:YAG comes in two types, frequency tripled which absorbs at 355 nm and quadrupled
at 266 nm [74]. The energy absorbed is transferred to the analyte, causing it to desorb
from the target plate. This creates a plume of ions which can be accelerated towards the
detector. In comparison to ESI, MALDI predominantly produces singly charged ions of
the general formula [M+H]+ and [M-H]-, independent of the mass. The ions will carry
different m/z ratios, therefore reaching the detector at different times to produce a mass
spectrum.

A.1.3 Comparison between ESI and MALDI

Both ESI and MALDI are “soft” ionization techniques allowing ionization of whole
biomolecules. As discussed, the methods of ionization vary drastically. Each carries its
own advantages and disadvantages. One of the major differences between ESI and
MALDI is the ability to couple ESI with LC. MALDI, unfortunately, does not possess the
capacity and is called an offline method. A second difference is that MALDI has a higher
tolerance towards salts, whereas ESI cannot have samples that contain too many. When a
sample has a higher concentration of salts, then MALDI may be the better choice. Lastly,
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both differ in the types of ions formed. ESI has the capacity to form multiply charged
ions, and because of this, is said to have an unlimited m/z range [74]. Analytes with
larger mass can simply appear as lower m/z peaks carrying multiple charges. The
production of multiply charged ions allows for the production of a larger number of
daughter ions in MS/MS. For instance, if the multiply charged ion is [M+4H]4+, then it
can be expected that a maximum of four daughter ions can be produced. With the
increase in the number of daughter ions, the greater the chances of confirming the amino
acid sequence. MALDI, in comparison, predominantly favours the formation of single
charged ions. Consequently, the MS/MS can only produce a maximum of one daughter
ion. Therefore, in comparison with ESI, the determination of the amino acid sequences
may not be as reliable. What is commonly seen in research today is to use LC-ESI-MS
for complex mixtures and MALDI MS for simpler ones. However, this need not be the
ultimate deciding factor. Which one should be used depends on what the technique is
applied towards, and what outcomes are being sought.

A.2 Proteomics

With the successful development of ESI and MALDI, the applications of MS became
focused on studying biological components. Emphasis was originally placed on studying
genes, collectively known as the genome; however, a shift towards studying proteins has
occurred within the past decades. The genome provides information corresponding to the
expression of proteins. The study of the proteome, that is all proteins expressed by the
cell at a given time and state, is what is called “proteomics” today. This allows for largescale investigations of the genome and cellular functions indirectly at the protein level
[75]. As such, proteomics is known to be as a post-genomic science [76].
In proteomics, the first crucial step is to isolate proteins from complex biological
mixtures. This alone is extensive and more challenging when compared to the genome.
Complications arise due to the fact that one gene can easily encode for several proteins
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differing anywhere from function to location [76]. In addition, the isolation of proteins is
difficult as a result of complex backgrounds and low abundances. And so, it is because of
these difficulties that an analytical technique such as mass spectrometry is needed. By
incorporating MS into the proteomic work flow, numerous types of biological
information can be explored.
One widely used application of MS is peptide mass fingerprinting (PMF). In PMF,
protein mixtures are subjected to site-specific enzymes, which will generate peptides.
These experimentally-determined peptides are then analyzed using MS. The resulting
spectra are searched against databases containing theoretical peptides produced from in
silico digests. Protein sequence databases, such as UniProtKB, are widely available.
These are libraries that house the genomes, and likewise the proteins they encode, for a
significant amount of species. Unfortunately, when the genome for a species has not been
completely identified, the protein database is also incomplete. As a consequence, when
running experimental data through them, matches may not occur. Of course, this does not
mean the obtained peptides are irrelevant.
When PMF does not provide sufficient information for identification, MS/MS can be
used to determine the amino acid sequences. Hunt et al. were able to sequence peptides
from apolipoprotein B [77]. Apolipoprotein B (apoB) is one of the proteins involved in
lipid metabolism. In their work, apoB was digested with the enzyme trypsin. Trypsin
cleaves on the C-terminal side of lysine and arginine, except when followed by proline.
The resulting peptides underwent MS/MS in a triple quadrupole mass spectrometer,
producing spectra where sequences were determined. The determination of these
sequences allowed for confirmation of the apoB protein.
Another common application of MS in proteomics is for the detection of posttranslational modifications of proteins. Once proteins are folded, they may undergo
further modification before being transported to their cellular location. For instance,
proteins undergo common modifications such as phosphorylation, the addition of
phosphate groups, or glycosylation, which is the addition of sugars. The addition of these
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groups will change the masses of said proteins, which can then be successfully
determined by MS [78].
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Appendix 2: Preparation of Media Used
Stock cultures of C. albicans were grown on Sabouraud dextorse agar (SDA) plates.
They were prepared as following:
1. Prepare a 6.50% (m/v) solution in water. Heat with stirring to aid in dissolution
2. Autoclave at 121°C for 25 minutes with a 10 minute steam down
3. Once cooled to room temperature, sterile polystyrene 100 mm x 15 mm Petri
dishes with stackable lids
4. The cooled plates are then placed into a 37°C oven overnight to ensure no
microbial growth has occurred

Yeast nitrogen base (YNB) broth was use for the cell growth of C. albicans. It can be
prepared as following:
1. Dissolve 6.70 g in 100 mL H2O to make the solution known as 10X YNB
2. Dissolve 18.00 g of sucrose in 900 mL H2O.
3. Supplement the sucrose solution with 100 mL of 10X YNB to make a final
volume of 1.00 L
4. Sterilize by autoclaving
5. Then filter the final solution

1X phosphate buffered saline (PBS) solution was for washings of cells and preparation of
adhered slides. It can be made according to the protocol below: :
1. Dissolve the four components in 800 mL H2O:
8.00 g of sodium chloride (NaCl)
0.20 g of potassium chloride (KCl)
1.44 g of sodium basic diphosphate (Na2HPO4)
0.24 g of monopotassium phosphate (KH2HPO4)
2. Bring the pH to 7.4 using hydrochloric acid (HCl)
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3. Then bring the final volume to 1.00 L using water
4. If necessary, sterilize the media via autoclaving
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Appendix 3: MALDI MS/MS Raw Spectrum

Once a list of peaks characteristic to C. albicans was determined, tandem mass
spectrometry (MS/MS) was performed. This second fragmentation would be able to
provide the specific amino acid sequence of the selected precursor ion. For a majority of
the peaks, second fragmentation was not possible due to the low ion counts. For an
adequate spectrum, the precursor ion should have an ion count of 2000. In the cases of
peaks that did meet this requirement, their spectra suffered significantly from
contamination and background noise. Figure A.3 is the MS/MS spectrum for the m/z peak
of around 1677, demonstrating this scenario. The presence of the m/z peak of around 175
did indicate that this was a peptide, as this corresponds to C-terminal arginine from a
tryptic digest. However, other than this, sequencing could not be done. The presence of
this many peaks did not allow for the differentiation between relevant amino acids and
non-informative background ions.
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Relative Intensity (%)

513.7

Figure A.3. MALDI MS/MS spectrum for the precursor ion with m/z = 1677.80.
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Appendix 4: Bicinchoninic Acid (BCA) Assay for Peptide Quantification
To meet the detection limit of the linear trap quadrupole (LTQ) mass spectrometer, 2 µg
of peptides were required. When working with peptides, who have molecular masses of
4000 Da or lower, the bicinchoninic acid (BCA) assay is ideal. The BCA assay relies on
the generation of a coloured complex between peptide bonds and the Cu2+ ion in alkaline
environments [79]. The concept of the BCA assay stems from the initially used Lowry
reagent, and today it is substituted as it has a higher salt tolerance. The BCA assay is
composed of two major reactions; the first is known as the biuert reaction, and the second
is chelation [79]. The biuret reaction is where an organic compound know as biuret reacts
with Cu2+ to form a light blue coloured complex [80]. This reaction is shown in Figure
A.4. The major product of this reaction is the Cu+ ion, which will be needed in the second
step of the BCA assay.

Figure A.4 The first reaction, known as the biuret reaction, of the BCA assay. This
reaction reduces Cu2+ to Cu+ through the binding of the amide bond, which will be needed
for the second half of the BCA assay [79].

As seen in Figure A.4, a single Cu2+ ion has the ability to bind to four to six amide bonds
[79]. In the second reaction shown in Figure A.5, the BCA reagent is chelated to the Cu+,
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producing the BCA-Cu complex. And it is this complex that allows for indirect
measurement of protein. Essentially, the amount of complex produced reflects how much
Cu+ is produced, which then ultimately indicates how many amide bonds were present to
cause the copper reduction. This complex absorbs strongly at a wavelength of 562 nm,
however measurements can be taken anywhere between 550 to 570 nm.

+

Figure A.5 The second reaction of the BCA assay. Here, Cu+ reacts with the BCA salt.
The production of the complex corresponds to the amount of protein originally bound to
the biuret reagent [79].

To create the standard curve, known concentrations of bovine serum albumin (BSA) were
used. A total of eight standards were used. The preparation volumes and final
concentrations are displayed in Table A.1.
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Table A.1 Standard BSA concentrations and volumes used to determine the standard
curve in the BCA assay.
Vial
A
B
C
D
E
F
G
H

Volume of H2O
(µL)
400
325
325
325
175
325
125
0

Volume OF BSA
(µL)
0
325 from C
325 from D
325 from F
325 from G
325
325
300

Measured BSA
Concentration (µg/mL)
0
125
200
500
750
1000
1500
2000

The protocol for performing the BCA assay was provided by the manufacturer (Fisher
Scientific, USA). The buffer in which the peptides are suspended in, in this case
ammonium bicarbonate, was diluted by a factor of ten. The diluted ammonium
bicarbonate was then mixed in a 1:1 (v/v) ratio with the BSA standards. 20 µL of this
mixture was pipetted into sixteen wells, two per concentration, in a 96 microwell plate.
For the digested peptides, they were diluted by a factor of ten using the diluted
ammonium bicarbonate. 10 µL of the diluted peptides were then pipetted into two wells
each, and were further diluted by the addition of 10 µL of water. Overall, this ensures the
total volume of standards and analytes were consistent. To each well, 180 µL of the BCA
reagent was added. The microwell plate was incubated at 37°C for 30 minutes. After 30
minutes, the plate was cooled to room temperature before measurements were taken.
Readings were taken on 1420 Multilabel Counter Victor3V (Perkin Elmer, Canada) at a
wavelength of 560 nm. The corresponding software used was the Perkin Elmer 2030
Manager.
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Appendix 5: ZipTip Protocol

Prior to analyses by HPLC-ESI-MS/MS, our digested peptides underwent sample cleanup
and concentration. This was accomplished by using 10 µL ZipTip C18. The protocol used
between different samples should be optimized. For our purposes, the protocol used in
our research will be discussed.
The list of solutions is as follows:
- wetting solution: 50% acetonitrile
- equilibration and wash solution: 0.1% trifluoroacetic acid
- elution solution: 80% acetonitrile
The protocol consists of five steps, which are described below:
1. Decontamination of the ZipTip using the wetting solution. This will remove nonspecific peptides.
a.

Using 40 µL, wet the resin by pipetting and expelling the waste. Perform
this twice

2. Equilibration with the equilibration and was solution. This will remove
acetonitrile
a.

Using 30 µL, introduce the solvent by pipetting and expelling the waste.
Repeat this two times

3. Acidification making the peptides negatively charged to bind the resin.
a. To acidify peptides, 0.5 µL increments of 0.5% trifluoroacetic acid are
added. The pH is checked after each addition until a pH of around 4 is
reached
b. The acidified peptides are then pipetted up and down ten times
4. Removal of ions from the ZipTip using the equilibration and wash solution.
Peptides will remain bound to the resin
a. Using 20 µL, the solution is pipetted up and down five times
5. Elution of peptides using the elution solution
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a. Using 5 µL of the solution, the peptides on the resin are pipetted up and
down ten times
b. The solution is kept as it contains the peptides
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